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ABSTRACT

Studies have shown the potential risks of neurodegeneration associated with chronic
consumption of plants of the Annonaceae family, which emphasize the need for further studies to
identify the neurotoxic compounds in the edible annonaceous plants and compare their risk to their
benefits in defeating cancer. Our study is focused on the alkaloidal constituents of two plants from
the Annonaceae family, Asimina triloba and Rollinia mocusa. This study was carried out to explore
the anticancer and neurotoxic constituents of the plants with the intention that separating
neurotoxic constituents would help in reducing the undesirable effects of the plants if it is used as
an alternative therapy.
Chapter II describes the phytochemical investigation of the alkaloids from Asimina triloba
twigs that yielded one new aporphine glycoside, (-)-anolobine-9-O-β-D-glucopyranoside 1, along
with seven known isoquinoline alkaloids, anolobine 2, nornuciferine 3, norushinsunine 4,
liriodenine 5, lysicamine 6, stepharine 7, and coclaurine 8. Alkaloids 3 and 6-8 are reported for the
first time from this plant.
In chapter III, the structural characteristics of eight alkaloids from methanolic extracts of
dried twigs of Asimina triloba have been studied using UHPLC-QToF-MS in positive ion mode.
This study described an investigation of the fragmentation pathways leading to the identification
of key diagnostic fragment ions for the annonaceous alkaloids.
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Chapter IV demonstrates the anticancer potential and the neurotoxicity of the isolated
alkaloids from Asimina triloba twigs. Six alkaloids (anolobine-9-O-β-D-glucopyranoside,
anolobine, norushinsunine, liriodenine, squamolone and coclaurine) were evaluated for their
anticancer potential in four human solid tumor cell lines (SK-MEL, KB, BT-549, and SK-OV-3).
The potential for neurotoxicity was determined using rat cortical neurons. Three extracts, namely
crude methanolic extract, alkaloids rich extract, and acetogenins rich extract, were also included
in the study to explore how the presence and the absence of the alkaloids or acetogenins will affect
the anticancer activity and neurotoxicity of this plant. This is the first report of anticancer activity
and the neurotoxic effect of the alkaloidal constituents of Asimina triloba.
Finally, chapter V describes the total synthesis of (±) anonaine, 3,4-methylenedioxy-1phenanthreneethylamine, (±) romucosine, and [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]methylcarbamate by using direct arylation reactions with 3,4-methylenedioxyphenethylamine 1
and 2-bromophenylacetic acid 2 in the preparation of aporphine analogues. The presence of the
synthesized compounds in Rollinia mucosa seeds and fruits was verified through the analytical
technique using UHPLC-QToF-MS. All synthesized compounds were subjected to the biological
evaluation to understand how they induce or reduce the cytotoxicity as well as neurotoxicity.
Improved accuracy and precision of the bioactive marker compounds and natural toxins in
the edible plants, dietary supplement, and natural health products will be helpful to the regulatory
agencies.
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CHAPTER I
INTRODUCTION

1.

Magnoliales

The order Magnoliales consists of six families (Annonaceae, Eupomatiaceae,
Degeneriaceae, Himantandraceae, Magnoliaceae, and Myristicaceae) (Soltis et al., 2004) (Figure
1-1). Among all the six families, the Annonaceae and Magnoliaceae are the most studied families.
The family of Eupomatiaceae consists of the single genus, Eupomatia, with three species
(Eupomatia bennettii F. Muell., Eupomatia laurina R. Br., and Eupomatia barbata Jessup) of
shrubs and trees occurring in tropical to temperate rainforests of Australia and New Guinea (Kim
et al., 2005). The family of Degeneriaceae has a single genus Degeneria, which is endemic to Fiji
(Cambie et al., 1992). Himantandraceae family also consists of a single genus, with one species,
called Galbulimima F.M. Bailey, which is found in Australia, New Guinea, and Indonesia (Brophy
et al., 2005). The family Myristicaceae is comprised of 20 genera and nearly 500 species, which
are a medium-sized family of angiosperm trees with a wide pan-tropical distribution (Sauquet
2003). The family Magnoliaceae consists of 12 genera and about 220 species of woody trees and
shrubs. The genera Magnolia (incl. Talauma), Liriodendron, Michelia, and Aromadendron have
been used in traditional folk medicine in Asia and North America (Schühly et al., 2001). The
Magnoliaceae contain secondary metabolites such as phenolic compounds, sesquiterpene lactones,
monoterpenes, and alkaloids, some with considerable in vitro bioactivities (Kelm and Nair 2000;
Son et al. 2000; Talapatra et al. 1982).
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Figure 1-1 The six families of Magnoliales order and their genus and species.

2. The family Annonaceae
The Annonaceae, also called the custard apple family, is the largest family in the Magnoliales
order. This family comprises of 135 genera and nearly 2500 species. Annonaceae are
predominantly grown in tropical and subtropical forests, except the Asimina genus that extends
into temperate regions. (Rabêlo et al. 2014). Some of the Annonaceae species are important in folk
medicine in treating various tumors and cancers. Also, many of them have valuable economic
importance as a source of large and pulpy edible fruits, such as pawpaw (Asimina triloba), Annona
cherimolia, Annona squamosa, Annona muricate, and Rollinia mucosa that are cultivated in many
countries (Rasai et al., 1995).
Furthermore, several Annonaceae plants are marketed as dietary supplements that promote
overall health. Among the dietary supplements, products that contain twig extracts of pawpaw
(Asimina triloba L. Dunal), e.g., Pawpaw Cell-Reg, or graviola (Annona muricata) are reported to
exhibited antitumor efficacy both in animal models and some clinical studies (McLaughlin et al.
2003).
Annonaceae plants contain a broad spectrum of biologically active acetogenins that have
been used for the treatment of different medical conditions. The acetogenins give Annonaceae
plants unique characteristics as anticancer, antioxidant, and anti-HIV agents at very low
concentrations with fewer side effects (Bermejo et al., 2005; McLaughlin 2008; Moghadamtousi
et al., 2015). Also, Annonaceae plants contain different alkaloids that are derived from
isoquinoline class including, benzyl-tetrahydroisoquinolines, protoberberines, proaporphines,
aporphines, oxoaporphines, and other miscellaneous alkaloids. Annonaceae alkaloids play critical
roles in folk treatments, and they possess anticancer, anti-bacterial, anti-inflammatory, and antiprotozoal activities (Lúcio et al., 2015).
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Furthermore, other different compounds have been isolated from Annonaceae plants,
including a number of flavonoids, some with the antioxidant activities (Gonda et al., 2000;
Ouattara et al., 2011). However, most of the literature are mainly focusing on the annonaceous
acetogenins and alkaloids, which have displayed a broad array of pharmacological effects and are
being clinically evaluated for the treatment of different diseases.

3. Annoaceous acetogenins
Annonaceous acetogenins are long-chain fatty acids (C32 or C34) that have been combined
with a terminal aliphatic side chain connecting to some hydrophilic functional groups, such as one
to three THF rings and several hydroxy groups. Biogenetically, they are derived from the
polyketide pathway. Annonaceous acetogenins were previously classified in terms of two major
structural factors, the terminal γ-lactone ring and the substituents on the long aliphatic chain into:
linear ACGs, epoxy ACGs, mono-tetrahydrofuran ACGs, bis-tetrahydrofuran and other
miscellaneous ACGs (Figure 1-2) (Alali et al., 1999; Zafra-Polo et al., 1998).
In 1982, the first discovery of the acetogenins, uvaricin, which was isolated from the root
of Uvaria accuminata by a group of scientists at the University of Arizona. Uvaricin (Figure 1-3)
demonstrated significant activity toward the P-388 lymphocytic leukemia in mice (Jolad et al.,
1982). Since then, AGGs have attracted significant scientific interest and more than 500 ACGs
isolated and identified from different Annonaceae plants.
The Annonaceous acetogenins are potent inhibitors of complex I (NADH: ubiquinone
oxidoreductase) of the mitochondrial electron transport systems, and they are potent inhibitors of
NADH oxidase of the plasma membranes of cancer cells. Complex I plays an essential role in the
maintenance of the bioenergetic function of the cell by driving the adenosine triphosphate (ATP)
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synthesis from the mitochondrial reducing equivalents produced in the central metabolic oxidative
pathways, which induces tumor cell apoptosis (programmed cell death) (Degli et al., 1994).

Figure 1- 2 Core units for classification of Annonaceous acetogenins (Alali et al., 1999)

5

Figure 1- 3 The chemical structure of uvaricin

Annonaceous acetogenins have been found to display a broad range of biological activities,
such as antitumor, antimalarial, anthelmintic, pesticidal, antiviral, and antimicrobial effects (Alali
et al., 1998; Coothankandaswamy et al., 2010; McLaughlin 2008; Pomper et al., 2009). Among
the broad array of biological activities reported in the biomedical literature for the AGEs, their
antitumor and cytotoxic effects have received the most attention.

4. Annonaceous alkaloids
Annonaceae plants contain Approximately 800 alkaloids that derived from isoquinoline
class, including simple isoquinolines, benzyltetrahydroisoquinolines, bisbenzylisoquinolines,
protoberberines, proaporphines, aporphinoids, oxoaporphines, phenanthrenes, and other
miscellaneous isoquinoline-type alkaloids (Lúcio et al., 2015) (Figure 1-4). The isoquinoline
alkaloids are a large group of important secondary metabolites that have significant
pharmacological importance. Many have been used extensively in folk medicine.
Annonaceous alkaloids possess diverse biological activities such as cytotoxicity (Wu et al.,
1995), antiplatelet aggregation activity (Chen et al., 1996), cardiovascular activity (Lin et al., 1994)
and antimicrobial activity (Ko et al., 1993).
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Figure 1- 4 A) simple isoquinolines, B) bisbenzylisoquinolines,
C) benzyltetrahydroisoquinolines, D) protoberberines, E) proaporphines,
F) aporphinoids, G) oxoaporphines, and H) phenanthrenes
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The anticancer effects of isoquinoline alkaloids are mainly related to their effect on cell
cycle arrest and DNA damage. Anonaine, an aporphine alkaloids, was reported to cause DNA
damage associated with increased intracellular nitric oxide, ROS, glutathione (GSH) depletion,
disruptive mitochondrial transmembrane potential, activation caspase 3, 7, 8 & 9 and poly ADP
ribose polymerase cleavage in human cervical cancer cell (HeLa) (Chen et al., 2008). Furthermore,
this alkaloid up-regulates the protein expression of p53 and Bax (Chen et al., 2008).
Also, studies have shown that liriodenine, an oxoaporphines, has induced apoptosis in
CAOV-3 cells via the mitochondrial signaling pathway by the involvement of caspase-3 and
caspase-9, inhibiting the proliferation of CAOV-3 cells )Nordin et al., 2015). Annonamine,
asimilobine, isolaureline, and (s)-narcorydine are aporphine alkaloids that have isolated from
Annonaceae plants and have demonstrated anticancer activities as well (Coria-Téllez et al., 2018).
Therefore, isoquinoline alkaloids, especially the aporphine type, are a promising potential drug
candidate for the treatment of cancer.

5. Overall aims
In spite of the success of some Annonaceae plants in the anticancer activity further
environmental lipophilic complex I inhibitors have been studied in different Annonaceae plants
and were found to cause decreased ATP levels in neuronal cell and redistribution of
phosphorylated tau protein from axons to the cell body, causing neuronal cell death (Paul et al.,
2013). Epidemiological studies have linked the consumption of Annonaceae plants to a high
prevalence of atypical parkinsonism in Guadeloupe (Stamelou et al., 2010; Escobar-Khondiker et
al., 2007). The potential risks of neurodegeneration associated with chronic consumption of the
fruits and tea leaves from Annonaceae plants emphasize the need for further studies to determine
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and identify the neurotoxic compounds in the edible annonaceous plants and compare their risk to
their benefits in defeating cancer.
Among the annonaceous plants, Asimina triloba (pawpaw) is one of the most efficient
Annonaceae plant species that can specifically interrupt the biochemistry of cancer cells, and its
extract has been found to be the most potent of more than 3000 species of higher plants screened
for bioactive compounds (McLaughlin 2008). It is the only species of Annonaceae with edible
fruits that grow in the temperate region and are native to North America (Brannan et al., 2018).
Pawpaw and many other Annonaceae plants are mainly consumed either as fresh fruits or
processed into ice creams, juices, liquors, and many other products. Moreover, its extract has
shown effective pesticidal and anticancer properties (Callaway et al., 1992). It is also currently
marketed as a dietary supplement for its potential use in alternative anticancer medicine.
This study focused on Asimina triloba specifically on its alkaloids constituents due to the
lack of studies on the isolation and identification of the alkaloids in this plant, only eight alkaloids
have previously reported from Asimina triloba (Figure 1-5) (Tomita et al. 1965; Zhao et al. 1993).
Moreover, our study concentrated on the alkaloidal constituents of Rollinia mucosa by
synthesizing some of its characteristic alkaloids and identify their biological benefits and safety.
Our central hypothesis is that the alkaloidal extract and pure alkaloids contribute to the cytotoxicity
of the Asimina triloba and Rollinia mucosa, and their presence would be a reason for the
neurotoxicity of these plants.

9

Figure 1- 5 Previously reported alkaloids from Asimina triloba
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The study and identification of the neurotoxic extracts and pure compounds would help in
the development of dietary supplements by choosing the plant extract that has the minimum
amount of the neurotoxin to reduce the possibility of undesirable side effects.
To render the cytotoxic and neurotoxicity effects of Asimina triloba (chapter iv) and
Rollinia mucosa (chapter v), different plant extracts and pure compounds were screened against
different cancer cell lines and cortical neurons. The twigs of Asimina triloba, which known to be
the most active part of this plant and has been used in the preparation of different dietary
supplements, were subjected to extraction with methanol to get the crude extract (rich with
alkaloids and acetogenins) followed by acid-base extraction to obtain alkaloidal rich extract and
alkaloids free extract (mainly contain acetogenins).
In chapter ii, the alkaloids rich extract was subjected to different column chromatography
to isolate and purify the alkaloids followed by structural elucidation and characterization by 1D
and 2D NMR spectroscopic and HRESI-MS spectrometric analysis. The isolated alkaloids from
Asimina triloba twigs were subjected to targeted analysis study using UHPLC-QToF in positive
ion mode to get their accurate MS and MS/MS experiments. Then, they were used as standards for
the analysis of two Asimina species (Asimina triloba and Asimina parviflora) and one dietary
supplement containing twigs of Asimina triloba, as described in chapter iii.
Alkaloids from Rollinia mucosa were obtained by the total synthesis of some of their
previously reported alkaloids (chapter v). Moreover, the presence of the synthesized compounds
in Rollinia mucosa seeds and fruits were verified through the analytical technique using UHPLCQToF-MS. The synthesized alkaloids were screened against different cancer cell lines and cortical
neurons to evaluate their biological activities.

11

To address our hypothesis, two aims will be executed: aim 1: chemical and biological
evaluations of Asimina triloba, and aim 2: synthesis of some alkaloids from Rollinia mucosa and
understanding their structure-activity relationships. The details of each aim are demonstrated in
chapter ii - v.
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CHAPTER II
ISOQUINOLINE ALKALOIDS FROM ASIMINA TRILOBA

1.

Introduction

Pawpaw (Asimina triloba [L.] Dunal) is native to the eastern United States (Galli et al.
2007). It belongs to the Annonaceae family, which is a large family of tropical and subtropical
trees and shrubs comprising about 129 genera and more than 2000 species (Rabêlo et al. 2014).
Pawpaw is mainly distributed in temperate forests of 26 states in the eastern United States,
extending from northern Florida to southern Ontario and as far west as eastern Nebraska (Galli et
al. 2007).
Previous phytochemical studies of pawpaw have led to the isolation of more than 50
bioactive compounds called acetogenins (McLaughlin 2008) that displayed antitumor,
antimalarial, anthelmintic, piscicidal, antiviral, and antimicrobial activities (Alali et al. 1998;
McLaughlin 2008; Pomper et al. 2009; Coothankandaswamy et al. 2010). Only a few alkaloids
have been reported from this plant, including coreximine, asimilobine, isocorydine, squamolone,
anolobine, liriodenine, norushinsunine and squamolone (Tomita et al. 1965; Zhao et al. 1993).
In the present study, a phytochemical investigation of Asimina triloba twigs was
undertaken to explore their alkaloidal constituent. Eight aporphine alkaloids including a new
aporphine glycoside, (-)-anolobine-9-O-β-D-glucopyranoside (1), were isolated, and their
structures (Figure 2- 1) were determined by 1D and 2D NMR spectroscopic and HRESI-MS
spectrometric analysis.
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Figure 2- 1 Structures of isolated alkaloids from Asimina triloba
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2.

Results and discussion

Compound 1 was obtained as a yellowish-brown amorphous powder. The HRESIMS (m/z
444.1655 [M+H]+, calcd 444.1658) established the molecular formula as C23H25NO8, indicating
12 degrees of unsaturation. The UV spectrum of 1 showed absorption (λmax) at 275 nm. The IR
spectrum showed band for secondary amine that overlapped with a hydroxyl group at 3358 cm -1.
The decoupled

13C

NMR spectrum of 1 exhibited 23 resonances, which were differentiated by

DEPT NMR spectrum as five methylenes, ten methines, and eight non-protonated carbons.
The 1H and 13C NMR spectra exhibited characteristic resonances for the methylenedioxy
group [δH/δC 5.96 (brd. s, 1H), 6.09 (brd. s, 1H)/100.8], four aromatic methines [δH/δC 6.60
(s)/107.7 (CH-3), 6.97 (d, J = 2.3 Hz)/116.3 (CH-8), 6.98 (dd, J = 9.4, 2.3 Hz)/115.6 (CH-10),
7.90 (d, J = 9.4 Hz)/128.1 (CH-11)], and a glucopyranose [δH/δC 4.90 (d, J = 7.5 Hz)/100.9 (CH1'), δC 73.7 (C-2'), 77.1 (C-3'), 70.2 (C-4'), 77.6 (C-5'), and 61.1 (C-6')] (Table 2- 1). The glucose
unit was located at C-9 due to the correlation of anomeric proton (H-1') with C-9 (δC 157.1) in the
HMBC spectrum.
The HMBC correlations of methylenedioxy protons with C-1 (δC 141.7) and C-2 (δC 146.5)
confirmed its position at C-1 and C-2 (Figure 2- 2). The absolute configuration at the stereogenic
center C-6a of compound 1 and its aglycone, anolobine (2), were determined as R from their
characteristic negative cotton effect (CE) at 237 and 235 nm respectively, (Figure 2- 3) (Ringdahl
et al. 1981).
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Figure 2- 2 Key HMBC (→) and COSY (▬) correlations of 1

The NMR data of the aglycone part of 1 was in agreement with those of anolobine (Chen
et al. 1997; Guo et al. 2011; Costa et al. 2015). Therefore, the structure of 1 was elucidated as (-)anolobine-9-O-β-D-glucopyranoside. Aporphine glycosides are rare alkaloids. So far, only seven
aporphine glycosides have been reported (Dary et al. 2017; Dembitsky VM. 2005), and anolobine9-O-β-D-glucopyranoside 1 is the first aporphine glycoside with anolobine 2 as the aglycone.
Known alkaloids were identified as anolobine (2), nornuciferine (3), norushinsunine (4),
liriodenine (5), lysicamine (6), stepharine (7) and coclaurine (8) by analyzing their NMR and mass
data (Figure 1- 1). Compounds 3 and 6-8 are reported for the first time from this plant.
The assignment of the absolute configurations at C-6a of the proaporphine alkaloid,
stepharine 7, and the tetrahydrobenzylisoquinoline alkaloid, coclaurine 8, were determined by CD
experiment. Stepharine (7) showed negative CE at 225 and 295 nm (Figure 2- 4) in contrast to the
previously reported (S)-(+)-stepharine, which has positive CE at 266 and 293 nm, suggesting R
configuration at C-6a (Snatzke et al. 1966).
The hypsochromic shift at 220 of stepharine indicated that it afforded the conformation of
type D(b) proaporphine alkaloids in which there is no overlap between the π-system of the dienone
group and the oxygen p-orbital of 1-OMe group, and the bathochromic shift of the (S)-(+)-
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stepharine at 266 is due to overlapping between the π-system and the oxygen p-orbital (Snatzke et
al. 1966).

Figure 2- 3 CD spectra of anolobine-9-O-β-D-glucopyranoside 1 and its aglycone (anolobine 2)

Coclaurine (8) demonstrated negative CE at 220 and 293 (Figure 2- 5), resembled to (R)(+) isotembetarine perchlorate (negative CE at 236 and 285) (Moriyasu et al. 1997) instead of (S)(+)-reticuline (positive CE at 240 and 290) (Nishiyama et al. 2000), supporting R configuration at
C-6a of coclaurine. The stereochemistry of stepharine and coclaurine at C-6a was further supported
by comparing their optical rotation values [α]25D −110 (Chen et al. 1997) and [α]25D +16 (Stadler
et al. 1988), respectively, with the reported optical rotation values.
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Figure 2- 4 CD spectrum of stepharine (7)

Figure 2- 5 CD spectrum of coclaurine (8)
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3.

Experimental

3.1. Apparatus and reagents
Circular Dichroism data are obtained from Olis DSM 20 CD digital subtractive method
circular dichrometer with a desa subtractive double grating monochromator. Rudolph Research
Analytical Autopol IV automatic polarimeter was used to obtain the specific rotations. IR spectra
were recorded on an Agilent Technologies Cary 630 FTIR. UV spectrum was acquired on a Varian
Cary 50 Bio UV-visible spectrophotometer. NMR spectra were obtained on Bruker AU III 400 or
500 MHz NMR spectrometers using DMSO-d6, CD3OD, or CDCl3 solvents. An Agilent
Technologies 6200 series mass spectrometer was used to record mass spectra. Column
chromatography was carried out using flash silica gel (40 μm, 60 Å, J. T. Baker). TLC was
performed on aluminum-backed plates, pre-coated with silica gel F254 (200 μm, 60 Å, (Merck).
Spots were detected at UV-254 nm. Visualization was attained by spraying with Dragendorff’s
reagent or with 1% vanillin solution (prepared with 5% H2SO4 in EtOH) followed by heating.
Preparative-TLC plates (20 cm × 20 cm, 500 μm) were utilized for the purification.

3.2. Plant material
Asimina triloba twigs were received from Dr. Jerry McLaughlin (Tippecanoe County,
Indiana). Voucher specimens (#17328) were deposited at the National Centre for Natural Products
Research, University of Mississippi, USA.

3.3. Extraction and Isolation
The plant material was finely powdered (1 kg) and extracted with methanol to obtain 25 g
of extract. An aliquot of MeOH extract (20 g) was subjected to usual acid-base alkaloidal
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extraction. The extract was suspended in 2% HCl (500 mL) and extracted with EtOAc (3 × 500
mL) in a separating funnel. After separating the EtOAc layers, the resulting aqueous acidic layer’s
pH was adjusted to 9−10 with ammonia solution and subsequently extracted again with EtOAc (3
× 500 mL). The combined EtOAc layers from basified solution were dried to give an alkaloidal
extract (1.3 g), which was fractionated by column chromatography (CC) (115 cm × 3 cm) using
silica gel and eluted with following solvents systems: CHCl3 (1L), CHCl3- CH3OH [9:1 (2 L)],
and EtOAc-CHCl3- CH3OH-H2O [15:8:2:0.5 (2 L) and 6:4:4:1 (2 L)] to give 5 fractions (Frs. 1-5)
and one pure compound [anolobine-9-O-β-D-glucopyranoside 1 (16 mg)]. Fr. 1 (66.8 mg) was
subjected to CC over silica gel [(84 cm × 1.3 cm), EtOAc-CHCl3-CH3OH-H2O (6:4:4:1)], followed
by preparative thin layer chromatography (PTLC) [EtOAc-CHCl3- CH3OH-H2O (6:4:4:1)] to give
stepharine (3.5 mg). Fr. 2 (46.6 mg) was subjected to PTLC [silica gel, CHCl3-CH3OH (30:1)],
which yielded a mixture of liriodenine and nornuciferine (23%:66%, 4.3 mg) and another mixture
of lysicamine and liriodenine (60%:40%, 1.4 mg). Fr. 3 (93.2 mg) was chromatographed over
silica gel [(85 cm × 2 cm), EtOAc-CHCl3-CH3OH-H2O (10:6:4:1)] followed by PTLC [EtOAcCHCl3-CH3OH-H2O (10:6:4:1)] to purify norushinsunine (2.4 mg). Fr. 4 (201.0 mg) was subjected
to CC over silica gel [(98 cm × 2.4 cm), CHCl3-CH3OH (17:3), followed by PTLC [CHCl3CH3OH-H2O (8:2:0.5)] to afford anolobine (2.0 mg). Coclaurine (2.6 mg) was purified from Fr. 5
(80.1 mg) by CC [silica gel (84 cm × 1.3 cm), CHCl3-CH3OH-H2O (8:2:0.25)], followed by PTLC
[CHCl3-CH3OH-H2O (8:2:0.25)].

3.3.1. (R)-(-)-anolobine-9-O-β-D-glucopyranoside (1)
Yellowish brown amorphous powder; HRESIMS m/z 444.1655 [M+H]+ (calcd. for
[C23H25NO8 + H], 444.1658); IR (KBr) νmax 3358, 3329, 2920, 2849,1608, 1228, 1045 cm−1; [α]25D
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: −15 (c = 0.5, CH3OH); UV/Vis λmax (CH3OH) nm (log ε): 210 (3.8), 275 (3.6); 1H NMR (500
MHz, DMSO-d6): δ 7.90 (1H, d, J = 9.4 Hz, H-11), 6.98 (1H, dd, J = 9.4, 2.3 Hz, H-10), 6.97 (1H,
d, J = 2.3 Hz, H-8), 6.60 (1H, s, H-3), 5.96 and 6.09 (each 1H, brd. s, –OCH2O–), 4.90 (1H, d, J =
7.5 Hz, H-1'), 3.69 (2H, overlapped, H-6a and H-6'), 3.48 (1H, dd, J = 11.9, 5.8 Hz, H-6'), 3.35
(1H, ddd, J = 9.1, 5.8, 2.1 Hz, H-5'), 3.23 - 3.31 (2H, overlapped, H-2' and H-3'), 3.18 (1H, t, J =
9.1 Hz, H-4'), 3.15 (1H, m, H-5), 2.83 (1H, dd, J = 14.5, 4.8 Hz, H-7β), 2.79 (1H, m, H-4), 2.77
(1H, m, H-5), 2.57 (1H, t, J = 14.5, H-7α), and 2.53 (1H, m, H-4). 13C NMR (125 MHz, DMSOd6): δ 157.1 (C-9), 146.5 (C-2), 141.7 (C-1), 137.7 (C-7a), 128.5 (C-11c), 128.1 (C-11), 127.6 (C3a), 125.0 (C-11a), 116.3 (C-8), 115.6 (C-10), 115.0 (C-11b), 107.7 (C-3), 100.9 (C-1'), 100.8
(−OCH2O–), 77.6 (C-5'), 77.1 (C-3'), 73.7 (C-2'), 70,2 (C-4'), 61.1 (C-6'), 53.5 (C-6a), 43.3 (C-5),
37.1 (C-7), and 29.5 (C-4) (Table 2- 1, Figure 2- 6).

Figure 2- 6 Anolobine-9-O-β-D-glucopyranoside (1)
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Table 2- 1 1H and 13C NMR data of anolobine-9-O-β-D-glucopyranoside (1) (DMSO-d6, 500
MHz/150 MHz)

No.

Mult.

δ 13C [ppm]

δ 1H [ppm]

1

C

141.72

-

2

C

146.49

-

3

CH

107.65

6.597 (s)

3a

C

127.63

4

CH2

29.46

2.532 (m)
2.790 (m)

5

CH2

43.29

2.772 (m)
3.151 (m)

6a

CH

53.53

3.699 (overlapped)

7

CH2

37.12

2.570 (t, J = 14.5, H-7α),
2.832 (dd, J = 14.5, 4.8 Hz, H-7β)

7a

C

137.71

-

8

CH

116.35

6.972 (d, J = 2.3 Hz)

9

C

157.09

-

10

CH

115.61

6.981 (dd, J = 9.4, 2.3 Hz)

11

CH

128.14

7.905 (d, J = 9.4 Hz)

11a

C

125.01

-

11b

C

114.99

-

11c

C

128.53

-

OCH2O

CH2

100.83

5.963, 6.089 (each brd. s)

1'

CH

100.86

4.901 (d, J = 7.5 Hz)

2'

CH

73.72

3.234 - 3.312 (overlapped)

3'

CH

77.12

3.234 - 3.312 (overlapped)

4'

CH

70.19

3.180 (t, J = 9.1 Hz)

5'

CH

77.57

3.353 (ddd, J = 9.1, 5.8, 2.1 Hz)

6'

CH2

61.14

3.699 (overlapped)
3.487 (dd, J =11.9, 5.8 Hz)
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3.3.2. (R)-(-)-Anolobine (2)
Light yellow powder; HRESIMS m/z 282.1133 [M+H]+ (calcd. for [C17H15NO3 + H], 282.1130);
[α]25D: −22 (c = 0.5, CH3OH); 1H and 13C NMR data matched with the literature (Chen et al. 1997;
Guo et al. 2011; Costa et al. 2015).

3.3.3. Nornuciferine (3)
Yellow amorphous powder; HRESIMS m/z (282.1486) [M+H]+ (calcd. for [C18H19NO2 + H],
282.1494). 1H and 13C NMR data matched with literature (Hasrat et al. 1997; Hsieh et al. 1999).

3.3.4. (-)-Norushinsunine (4)
Light brown solid mass; HRESIMS m/z 282.1123 [M+H]+ (calcd. for [C17H15NO3 + H], 282.1130);
[α]25D: −40 (c = 0.1, CH3OH); 1H NMR data matched with the literature (Chen et al. 1997; Hsieh
et al. 1999).

3.3.5. Liriodenine (5)
Yellow amorphous powder (in mixture form with nornuciferine); HRESIMS m/z (276.0656)
[M+H]+ (calcd. for [C17H9NO3 + H], 276.0661). 1H and

13C

NMR data matched with literature

(Chen et al. 1997; Guo et al. 2011).

3.3.6. Lysicamine (6)
Yellow powder; HRESIMS m/z 292.0968 [M+H]+ (calcd. for [C18H13NO3 + H], 292.0974); 1H and
13C

NMR data matched with literature (Chen et al. 1997; Rabêlo et al. 2015).
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3.3.7. (R)-(-)-Stepharine (7)
Dark brown solid mass; HRESIMS m/z 298.1439 [M+H]+ (calcd. for [C18H19NO3 + H], 298.1443);
[α]25D: −110 (c = 0.1, CHCl3); 1H and 13C NMR data matched with the literature (Chen et al. 1997;
Costa et al. 2015; Rabêlo et al. 2015).

3.3.8. (R)-(+)-Coclaurine (8)
Colorless prisms (CH3OH); HRESIMS m/z 286.1437 [M+H]+ (calcd. for [C17H19NO3 + H],
286.1443); [α]25D +16 (c = 0.25, CH3OH); 1H and 13C NMR data matched with the literature (Costa
et al. 2015).

4.

Conclusion

The phytochemical investigation of the alkaloids from Asimina triloba twigs yielded one
new aporphine glycoside, (-)-anolobine-9-O-β-D-glucopyranoside (1), along with seven known
isoquinoline alkaloids, anolobine (2), nornuciferine (3), norushinsunine (4), liriodenine (5),
lysicamine (6), stepharine (7) and coclaurine (8). Alkaloids 3 and 6-8 are reported for the first time
from this plant.
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CHAPTER III
TARGETED ANALYSIS OF ANNONACEOUS ALKALOIDS FROM ASIMINA TRILOBA
USING UHPLC-QTOF-MS

1.

Introduction

Standardization of botanical supplements is an essential tool in the formulation of highquality dietary supplements. The development of an analytical method to characterize and quantify
the biomarkers and chemical markers would be valuable not only for herbal identification and
quality control but would also enhance understanding of the botanicals’ biological activity and
their benefits or potential risk to human health.
Phytochemical and pharmacological investigations on Asimina species revealed the
presence of several bioactive compounds, including alkaloids, acetogenins, phenolic compounds,
terpenes, and essential oils (Leboeuf et al., 1980). Chemical studies of the plant (family
Annonaceae) have increased in the last two decades due to the presence of annonaceous molecules
(e.g., isoquinoline alkaloids and acetogenins) with pharmacological uses (González-Esquinca et
al., 2014). Approximately 500 alkaloids have been identified in 138 Annonaceae species in 43
genera.
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Most of these alkaloids present in Annonaceae possess isoquinoline derived structures
including benzyltetrahydroisoquinolines (coclaurine, higenamine), protoberberines (coreximine,
jatrorrhizine, berberine, corydaline, tetrahydropalmatine), proaporphines
stepharine),

aporphines

(anonaine,

asimilobine,

glaucine,

magnoflorine,

(pronuciferine,
isocorydine,

norisocorydine, norcorydine, lysicamine, nornuciferine), and oxoaporphines (liriodenine,
anolobine, norushinsunine, lanuginosine) (Leboeuf et al., 1980). The aporphinoids are the largest
group of compounds occurring in the Annonaceae plants (Leboeuf et al., 1980).
The presence of acetogenins was investigated in the Asimina triloba fruits using different
analysis techniques, including HPLC-MS (Pomper et al., 2009) and HPLC-DAD (Donno et al.,
2014). A quantitative liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was
established for the quality control of the acetogenins in the extracts of the pawpaw tree (Asimina
triloba). The concentrations of the three major compounds (bullatacin, asimicin, and trilobacin)
were evaluated (Gu et al., 1999). A droplet-liquid microjunction-surface sampling probe coupled
to UPLC-PDA-HRMS/MS system was used to detect acetogenins in situ from Asimina triloba
(Sica et al., 2016).
The alkaloid liriodenine was analyzed by the TLC image analysis and HPLC-DAD method
from twenty-eight plant materials of Magnoliaceae, Annonaceae and Nelumbonaceae in Thailand
(Mongkolrat et al., 2013). The levels of reticuline, norreticuline, and N-methylcoclaurine were
determined in three Annona species (A. reticulata, A. squamosa, A. muricata) (Kotake et al., 2004).
Previous studies have evaluated the analysis to a specific type of plant or acetogenins or alkaloids
from Annona or Asimina species (Donno et al., 2014; Mongkolrat et al., 2013; Pomper et al., 2009;
Ratnayake et al., 1992; Yang et al., 2009).
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Most of the previous work was focused on target acetogenins or alkaloids with limited
information on alkaloids from Asimina triloba samples. In this regard, metabolomics provides an
efficient tool for investigating the alkaloids in a single analysis, including health promoting
compounds.
Utilizing the high chromatographic resolution and separation capabilities of UHPLC with
QToF-MS provides the structural characterization from accurate mass measurement for both MS
and MS-MS experiments. This technique offers a significant advantage for the rapid screening of
compounds in complex matrices. In the present study, the structural characteristics of 8 alkaloids
from methanolic extracts of dried twigs of Asimina triloba have been studied using UHPLC-QToFMS in positive ion mode.
Herein, this study described an investigation of the fragmentation pathways leading to the
identification of key diagnostic fragment ions for the annonaceous alkaloids. MS-MS experiments
lessen the ambiguities in the identification of compounds. Because of the many isomers, even
accurate mass MS/MS is insufficient for complete identification, requiring chromatographic
separation and comparison of standards. Alkaloids were characterized and confirmed from their
retention times obtained from standard compounds.

2.

Experimental approach

The high chromatographic resolution and separation capabilities of the UHPLC with
QToF-MS have been applied to the identification and characterization of isolated alkaloids
(anolobine-9-O-β-D-glucopyranoside, anolobine, nornuciferine, norushinsunine, liriodenine, and
lysicamine, stepharine, and coclaurine) from Asimina triloba (Majrashi et al., 2018).
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The standard compounds were characterized and detected from methanolic extracts of
different parts of Asimina triloba, Asimina parviflora, and one dietary supplement claiming to
contain pawpaw (Asimina triloba) and identified by comparing the retention times and the MS and
MS/MS data with reference standards. No previous phytochemical work has been reported with
species of Asimina parviflora except for one paper where five bioactive compounds (asimicilone,
6-cis-docosenamide, asimicin, (+)-syringaresinol, and β-sitosterol-β-D-glucopyranoside) were
isolated and identified (Ratnayake et al., 1992). Herein, the standard compounds have been used
to distinguish between the two Asimina species, triloba and parviflora.

3.

Plant materials

Dried seed (NCNPR code # 17325), twigs (NCNPR code # 17328), bark (NCNPR code #
17326), and twigs with bark (NCNPR code # 17327) of Asimina triloba were obtained by Dr. Jerry
McLaughlin at Purdue University’s School of Pharmacy (West Lafayette, IN). Leaf (NCNPR code
# 19098), stem (NCNPR code # 19099), root (NCNPR code # 19100) of Asimina parviflora, were
provided by David Ellis (Botanist, PurdueUniversity, West Lafayette, Indiana). Dietary
supplement (#18447) claiming to contain pawpaw (Asimina triloba twigs extract) was purchased
online. Specimens of all samples were deposited at the NCNPR’s botanical repository at the
University of Mississippi.

4.

Standards and plant sample preparation

All standards were prepared at a concentration of 10 µg/mL. Dry plant samples (0.5 g) or
an adequate amount of capsule contents (average weight of dosage form) or 25 mg of extracts were
sonicated in 2.5 mL of methanol for 30 min, followed by centrifugation for 15 min at 959 × g. The
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supernatant was transferred to a 10 mL volumetric flask. The procedure was repeated three more
times, and the respective supernatants were combined. The final volume was adjusted to 10 mL
with methanol and mixed thoroughly. Prior to injection, an adequate volume (ca. 2 mL) was passed
through a 0.45 µm PTFE membrane filter. The first 1.0 mL was discarded, and the remaining
volume was collected in an LC sample vial.

5.

Instrumentation and analytical conditions

5.1.

Ultra-High-Performance Liquid Chromatography-Quadrupole Time of

Flight-Mass Spectrometry (UHPLC/QToF-MS)
The liquid chromatographic system was an Agilent Series 1290 comprised of the following
modular components: binary pump, a vacuum solvent microdegasser, an autosampler with a 100well tray and a thermostatically controlled column compartment. The separation was achieved on
an Agilent Poroshell 120 EC-18 (2.1×100 mm, 2.7 µ) column. The mobile phase consisted of water
with 0.1% formic acid (A) and acetonitrile with 0.1% formic acid (B) at a flow rate of 0.23 mL/min,
with the following gradient: 0 min, 2% B in next 20 min to 10% B, for next 30 min 20% B, for
next 20 min 50% B, for next 20 min 70% B, for next 20 min 90% B and to 100% B in next 10 min.
Each run was followed by a 5 min wash with 100% B and an equilibration period of 5 min with
2% B. Two microliters of sample were injected. The column temperature was set at 40 °C, and
UV spectra were recorded from 190-400 nm.
The mass spectrometric analysis was performed with a QToF-MS/MS (Model #G6530A,
Agilent Technologies, Palo Alto, CA, USA) equipped with an ESI source with Jet Stream
technology using the following parameters: drying gas (N2) flow rate, 11.0 L/min; drying gas
temperature, 325 °C; nebulizer, 30 psig, sheath gas temperature, 325 °C; sheath gas flow, 11
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L/min; capillary, 3000V; skimmer, 65V; Oct RF V, 750V; fragmentor voltage, 100V. The sample
collision energy was set at 55eV. All the operations, acquisition, and analysis of data were
controlled by Agilent MassHunter Acquisition Software Ver. A.05.00 and processed with
MassHunter Qualitative Analysis software Ver. B.07.00. Each sample was analyzed in a positive
mode in the range of m/z = 100-1700.
Accurate mass measurements were obtained by means of ion correction techniques using
reference masses at m/z 121.0509 (protonated purine) and 922.0098 [protonated hexakis (1H, 1H,
3H-tetrafluoropropoxy) phosphazine or HP-921] in positive ion mode. The compounds were
confirmed in each spectrum. For this purpose, the reference solution was introduced into the ESI
source via a T-junction using an Agilent Series 1200 isocratic pump (Agilent Technologies, Santa
Clara, CA, USA) using a 100:1 splitter set at a flow rate of 20 µL/min. For recording ToF-MS
spectra, the quadrupole was set to pass all ions (Rf only mode), and all ions were transmitted into
the pusher region of the time-of-flight analyzer where they were mass-analyzed with a 1 s
integration time up to m/z 1000. For the ESI-MS/MS CID experiments, ions of interest were massselected by the quadrupole mass filter. The selected ions then collided with nitrogen in a highpressure collision cell, and the collision energy was optimized to afford good product ion signals
that were subsequently mass measured with the ToF analyzer.
Analysis was performed in the reflectron mode with a resolving power of about 10,000 at
m/z 922. The instrument was set to extended dynamic range (up to 105 with lower resolving power).
MS/MS spectra were recorded simultaneously at a rate 2.0 spectra s −1. In order to filter selected
precursor ions and their isotopes for MS/MS, an isolation window of 1.3 m/z was set for the
quadrupole.
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5.2.

Data analysis

MassHunter Workstation software, including Qualitative Analysis (version B.07.00), was
used for processing both raw MS and MS/MS data, including molecular feature extraction,
background subtraction, data filtering, and molecular formula estimation (using accurate mass of
all isotopes, their relative abundances, and all detected adducts with their measured isotopes).
To perform subtraction of molecular features (MFs) originating from the background,
analysis of a blank sample (methanol) was carried out under identical instrument settings, and
background MFs were removed. This method involved the use of the [M+H] + and [M+Na]+ ions
in the positive ion mode, found in the extracted ion chromatogram (EIC).

6.

Results and discussion

In order to determine the optimal ionization method for analytes, positive and negative ion
modes were investigated with the same UHPLC mobile phase at a flow rate of 0.23 mL/min. All
compounds showed good detection in positive ion mode. Identification or elucidation of these
compounds using UHPLC-QToF-MS can be performed with the assistance of reference standards
(Table 3- 1). Some chromatographic peaks contained the same protonated molecules in the MS
spectra and similar product ions in MS/MS spectra but had different retention behaviors, which
were helpful for their identification.
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Table 3- 1 Accurate mass data, fragment ions for the alkaloids of Annonaceae family using
UHPLC Q-ToF
Name

Retention
Time
(min)

Molecular
formula

m/z

m/z

Calculated

Experimental

Error
(mDa)

Anolobine-9O-β-D-glucopyranoside

27.3

C23 H25 NO8

444.1653
[M+H]+

444.1653

0.0

Anolobine

39.5

C17 H15 NO3

282.1125
[M+H]+

282.1123

-0.2

Nornuciferine

36.3

C18 H19 NO2

282.1489
[M+H]+

282.1487

-0.2

Norushinsunine

39.0

C17H15NO3

282.1125
[M+H]+

282.1125

0.0

Liriodenine

48.2

C17H9NO3

276.0655
[M+H]+

276.0656

+0.1

Fragment Ions
(30V)

[M+H]+/
[M+Na]+
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427.1312 [M+H-NH3]+
265.0820 [M+H-NH3Glu]+
247.0759 [M+H-NH3 Glu-H2O]+
235.0712 [M+H-NH3 Glu- CH2O]+
217.0656 [M+H-NH3Glc-H2O-CH2O]+
207.0775 [M+H-NH3Glc- CH2O-CO]+
179.0842 [M+H-NH3Glc- CH2O-2CO]+
265.0839 [M+H-NH3]+
247.0731 [M+H-NH3H2O]+
235.0730 [M+H-NH3CH2O]+
217.0635 [M+H-NH3H2O-CH2O]+
207.079 [M+H-NH3CH2O-CO]+
179.0828 [M+H-NH3CH2O-2CO]+
189.0694 [M+H-NH3CH2O-CO-H2O]+

251.1048 [M+HCH3NH2]+
236.0817 [M+HCH3NH2-CH3]+
219.0791 [M+HCH3NH2-CH3OH]+
191.0844 [M+HCH3NH2-CH3OH-CO]+
264.1014 [M+H-H2O] +
234.0902 [M+H-H2OCH2O] +
206.0952 [M+H-H2OCH2O-CO] +
179.0845 [M+H-H2OCH2O-CO-NH3] +
248.0694 [M+H-CO]+
220.0743 [M+H-2CO]+
218.0591 [M+H-CO2CH3]+,
190.0643 [M+H-2CO 2CH3]+

Table 3- 2 Accurate mass data, fragment ions for the alkaloids of Annonaceae family using
UHPLC Q-ToF
Name

Retention
Time
(min)

Molecular
formula

Lysicamine

59.1

C18H13NO3

Stepharine

23.7

C18H19NO3

Coclaurine

23.1

C17H19NO3

m/z Calculated

292.0968
[M+H]+

Experimental

m/z

Error
(mDa)

[M+H]+/
[M+Na]+
292.0965

+0.3

298.1438
[M+H]+

298.1439

+0.1

286.1438
[M+H]+

286.1439

+0.1
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Fragment Ions
(30V)

277.0719 [M+HCH3]+
260.0695 [M+HCH3-17]+
248.0692 [M+HCH4-CO]+
231.0654 [M+HCH4-CO-17]+
219.0664 [M+HCH4-CO-29]+
281.1122 [M+HNH3]+
269.1140 [M+HCO]+
254.0896 [ M+HCO-CH3]+
238.0946 [M+HCO-OCH3]+
223.0733 [M+HCO-CH3-OCH3]+
192.0992 [M+HCO-CH3-2OCH3]+
161.0811 [M+HCO- CH33OCH3]+
146.0577 [M-CO2CH3-3OCH3] +
269.1155 [M+HNH3]+
254.0933 [M+HCH3OH]+
175.0747 [M+HC6H8NO]+
143.0483 [M+HC7H10NO-H2O]+
107.0493 [M+HC10H12O]+

Alkaloids isolated from Asimina triloba twigs have a secondary amine, and they are
composed of three-four rings with different skeletons. The ESI mass spectra of these alkaloids
showed abundant [M+H]+ ions due to the strong basicity of the secondary amine group. The data
were obtained in positive electrospray ionization mode at collision energies 30eV. Only singly
charged positive [M+H]+ were used to produce targeted MS-MS spectra. The alkaloids of the
aporphine, oxoaporphine, and benzylisoquinolines type represent the predominant group in this
genus. The alkaloidal skeleton was determined from the UV absorption spectra and mass
spectrometry fragmentation.

6.1.

Benzylisoquinoline alkaloids

The prototype molecule of coclaurine was identified based on exact mass measurement and
comparison with the standard compound. According to the structural characteristics, elution of
benzylisoquinolines was achieved before that of the other class of alkaloids. Major characteristics
ions were formed by inductive cleavage and α-cleavage at the nitrogen of the tyramine moiety
(Jeong et al., 2012; Schmidt et al., 2005) (Figure 3- 1, 3- 2). Coclaurine (m/z 286.1439 [M+H]+)
produced product ions at m/z 269.1155 [M+H-NH3]+, 254.0933 [M+H-CH3OH]+, 237.0905
[M+H-NH3-H2O]+, 209.0951, 194.0717, 143.0483, 115.054 and major fragment ion 107.0493
(Table 3- 1, Figure 3- 1, 3- 2). The UV absorption maxima of this compound were 200, 227, 283
nm.
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Coclaurine
MS

MS-MS

Figure 3- 1 ESI-MSn spectrum of coclaurine

Figure 3- 2 Tentative fragmentation pathways of the coclaurine
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6.2.

Proaporphine Alkaloids

Proaporphine Alkaloids, such as stepharine with the p-cyclohexadienone moiety, are the
precursor of aporphine alkaloids (Dai et al. 2012; Jeong et al., 2012; Tomita et al. 1965). The mass
spectrum showed the molecular ion peak at m/z 298.1439 [M+H]+, thus indicating a molecular
formula of C18H19NO3. The fragmentation peaks were observed at m/z 281.1122 [M+H-NH3]+, m/z
269.1140 [M+H-CO]+ attributed to the loss of amino and carbonyl groups from the dienone type
fragment. Additional peaks at m/z 254.0896 [M+H-CO-CH3]+, 238.0946 [M+H-CO-OCH3]+,
223.0733 [M+H-CO-CH3-OCH3]+, 192.0992 [M+H-CO-CH3-2OCH3]+, 161.0811 [M+H-COCH3-3OCH3] + and 146.0577 [M+H-CO-2CH3-3OCH3] + were observed.
The molecular ion is decomposed by RDA (retro-diels-alder) reaction of the
tetrahydroisoquinoline ring, and the process is similar to the fragmentation of aporphine alkaloids
(Table 3- 1, Figure 3- 3, 3- 4). The UV absorption spectrum, measured in methanol showed at
210, 234, and 285 nm.
MS

Stepharine
(4)

298.1439
100

MS-MS

1
46.0577

2
23.0733

2
69.1140

Figure 3- 3 ESI-MSn spectrum of stepharine
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Figure 3- 4 Tentative fragmentation pathways of the stepharine.

6.3.

Aporphine Alkaloids

Aporphine alkaloids are the largest group of isoquinoline alkaloids and due to their rigid
structures, the mass spectra are characterized by loss of small molecules such as water, CO, or CO 2
with cation radicals fragment ions frequently present. The degree of substitution on the nitrogen
can be identified on the loss of ammonia (secondary nitrogen), methylamine (tertiary nitrogen) or
dimethylamine (quaternary nitrogen) (Sangster and Stuart 1965; Shamma et al. 1971; Singh et al.,
2017; Tang et al., 2014; Tian et al. 2014).
Nornuciferine showed a protonated molecule [M+H]+ at m/z 282.1487 and the
fragmentation was due successive loss of methylamine group (–CH3NH2 [M+H-31]+ ), methyl
group (–CH3 group [M+H-15]+), -CH3OH moiety, -CO molecule produced ions at m/z 267.0906,
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251.1048, 236.0817, 219.0791, major fragment ion m/z 191.0844 (Table 3-1, Figure 3-5, 3-6) and
UV absorption spectra at 215, 270 and 310 nm.

Nornuciferine

MS

MS-MS

2
08.0867

Figure 3- 5 ESI-MSn spectrum of nornuciferine.

Figure 3- 6 Tentative fragmentation pathways of the nornuciferine
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Similar the case with lysicamine where it showed a protonated molecule [M+H]+ at m/z
292.0965 and the fragmentation was due to successive loss of methyl group (-CH3 group [M+H15]+), -CH4-CO moiety, CO molecule produced ions at m/z 277.0719 (major), 260.0695, 248.0692
(major), 191.0705 (Table 3- 1, Figure 3- 7, 3- 8) and UV absorption spectra at 215, 275 and 310
nm.

Lysicamine

MSS

MS-MS

Figure 3- 7 ESI-MSn spectrum of lysicamine
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M

Figure 3- 8 Tentative fragmentation pathways of the lysicamine

6.4.

Oxoaporphine Alkaloids

Liriodenine, norushinsinine, anolobine, and anolobine-9-O-β-D-glucopyranoside of this
group of alkaloids were identified based on comparison with standard compounds. The mass
spectrum of these compounds revealed molecular ions at 276.0656, 282.1125, 282.1123 and
444.1653, respectively, corresponding to protonated molecule [M+H]+. The fragmentation of the
protonated molecular ion of liriodenine led to product ions of m/z 248.0694, 220.0743, 218.0591,
190.0643.
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The product ion at m/z 248 and m/z 220 were formed by successive losses of -CO from the
molecular ion at m/z 276. The more abundant product ion at m/z 190.0649 was formed by the loss
of a carbonyl and –CH3 groups (Table 3- 1, Figure 3- 9, 3- 10). The UV absorption maximum
found to be 200, 255, 277, 330, and 399 nm, corresponds with the oxoaporphine skeleton.

Liriodenine

MS

MS-MS

Figure 3- 9 ESI-MSn spectrum of liriodenine
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Figure 3- 10 Tentative fragmentation pathways of the liriodenine

Norushinsinine, the fragmentation of the protonated molecular ion at m/z 282.1125 led to
successive losses of 18, 30, and 28 Da, which indicate losses of water, -CH2O and -CO
corresponding to product ions of m/z 264.1014, 234.0902, 206.0952, and 179.0845. The more
abundant product ion was m/z 206.0952 (Table 3- 1, Figure 3- 11, 3- 12). The UV absorption
maximum found to be 205, 235, 245, 271, 280, and 318 nm.
Norushinsunine

MS

MS-MS

Figure 3- 11 ESI-MSn spectrum of norushinsunine
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Figure 3- 12 Tentative fragmentation pathways of the norushinsinine

The protonated molecule at m/z 282.1123 (anolobine) presented mass fragment ions at m/z
265.0839, 247.0731, 235.0730, 219.0778, 217.0635, 207.079, 189.0694, and 179.0828 with losses
of 17, 18, 28, and 30 Da, corresponding to NH3, H2O, CO, and CH2O (Table 3- 1, Figure 3- 13,
3- 14).
Anolobine

MS
282.1123
100

MS-MS

1
89.069
4

2
17.063
5

Figure 3- 13 ESI-MSn spectrum of anolobine
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Figure 3- 14 Tentative fragmentation pathways of the anolobine
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Anolobine-9-O-β-D-glucopyranoside exhibited a protonated molecular ion at m/z
444.1655 (C23H25NO8). The parent ion showed fragment ions at m/z 427.1312 [M+H-NH3]+ and
the ion at m/z 265.0820 [M+H- NH3-glucose] indicating a loss of dehydrated hexose (C6H10O5)
moiety. The UV absorption maximum found to be 213, 230, 276, 285, and 320 nm (Table 3- 1,
Figure 3- 15, 3- 16).

Anolobine-9-O-β-D-glucopyranoside

MS
444.1655
100

MS-MS

2

17.0656

Figure 3- 15 ESI-MSn spectrum of anolobine-9-O-β-D-glucopyranoside
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Figure 3- 16 Tentative fragmentation pathways of the anolobine-9-O-β-D-glucopyranoside

Twigs and bark of Asimina triloba indicated the presence of all eight reference compounds
(Table 3- 1, 3- 2). Leaf, stem, and root of As. parviflora showed for the presence of six standards.
However, anolobine and lysicamine were not detected. Liriodenine, coclaurine, norushinsunine,
and stepharine were common to all samples analyzed.
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Anolobine-9-O-βD-glucopyranoside
Anolobine
Nornuciferine
Norushinsunine
Liriodenine
Lysicamine
Stepharine
Coclaurine

1
2
3
4
5
6
7
8

Name

#

+
+
+
+
ND
+
+

+

Mixed

ND
+
+
+
ND
+
+

+
+
+
+
+
+
+
+

+

Bark

+
+
+
+
+
+
+

+

Bark

Asimina triloba Plant Part

+
+
+
+
+
+
+

+

+
+
+
+
+
+
+

+

Prod.

ND
ND
+
+
ND
+
+

ND

ND
+
+
+
ND
+
+

+

Asimina parviflora

Table 3- 3 Targeted analysis of As. triloba plant parts using UHPLC-QToF-MS

ND
ND
+
+
ND
+
+

ND

The MS-MS of eight standards were investigated using UV spectra and ESI-MS-MS
technique to determine diagnostic ions based on the structural characteristics of alkaloids in
Asimina species. On the basis of the fragmentation patterns of the secondary, tertiary, and
quaternary alkaloids, the alkaloids extracted from As. triloba were tentatively identified and
characterized using the UHPLC-QToF technique. These compounds comprising of
benzylisoquinoline, aporphine, oxoaporphine, and proaporphine were identified by interpreting
the MS-MS spectra based on different alkaloidal structures. Several pharmacological activities for
these compounds were previously observed, including anti-acetylcholinesterase, antioxidant,
antidepressant, antiepileptic, antimicrobial, antileishmanial, antitrypanosomal, antiplasmodial,
antiproliferative, antibacterial, antifungal, antiulcer, cytotoxic, immune-stimulant, and anxiolyticlike (Egydio-Brandão et al., 2017).

7.

Conclusion

UHPLC-QToF-MS has been applied to the identification and characterization of alkaloids
from Asimina triloba and Asimina parviflora. The standard compounds were characterized and
detected from methanolic extracts of the two Asimina species. The compounds were identified by
comparing the retention times and the MS and MS/MS data with reference standards. Finally,
because of the simple sample preparation and high reproducibility, the developed analytical
method would be valuable not only for herbal identification and quality control but would also
enhance understanding of the biological activity and their benefits to human health.

49

Chapter III Copyright

The content of chapter iii has been published in the Journal of Pharmaceutical and Biomedical
Analysis. The journal offers reuse of the articles by the author for thesis or dissertation, the
permission is not required as shown below.

The reference of the full article is:
Avula B, Bae J, Majrashi T, et al. Targeted and non-targeted analysis of annonaceous alkaloids
and acetogenins from Asimina and Annona species using UHPLC-QToF-MS. Journal of
Pharmaceutical and Biomedical Analysis. 2018;159:548-566.

50

CHAPTER IV
CYTOTOXIC AND NEUROTOXIC POTENTIAL OF ALKALOIDAL CONSTITUENTS OF
ASIMINA TRILOBA

1. Introduction
Annonaceae is the largest plant family of the magnoliales, which has over 120 genera and
about 2,100 species (Aminimoghadamfarouj et al., 2011; Brannan et al., 2018). Plants belonging
to the Annonaceae family are found mainly in the tropics or subtropics (Leboeuf et al., 1980),
except the Asimina genus that extends into temperate regions (Hormaza, 2014). Some of the
Annonaceae species are important in folk medicine. They have been used to treat various cancers
(Quílez et al., 2018), and many of them have valuable economic importance as a source of large
and pulpy edible fruits, such as pawpaw (Asimina triloba), custard apple (Annona cherimola),
sugar apple (Annona squamosa), graviola (Annona muricata) and biriba (Rollinia mucosa) (Rasai
et al., 1995).
Annonaceae plants contain a broad spectrum of biologically active acetogenins that have
displayed antitumor, antimalarial, anthelmintic, pesticidal, antiviral, and antimicrobial effects
(Alali et al., 1998; Coothankandaswamy et al., 2010; McLaughlin, 2008; Pomper et al., 2009) and
have been used for the treatment of various medical conditions. Also, Annonaceae plants contain
different sub-classes of alkaloids that are derived from isoquinoline class, including, benzyltetrahydroisoquinolines, protoberberines, proaporphines, aporphines, oxoaporphines, and other
miscellaneous isoquinolines (Cave, 1985).
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The popularity of the Annonaceae plants and their potential health effects (especially their
anticancer activities) has grown in recent years, despite studies that have shown the development
of atypical parkinsonism in people who consume large amounts of annonaceous products
(McLaughlin, 2008; Stamelou et al., 2010). The underlying neurotoxicity related to chronic
consumption has been linked to some acetogenins (e.g., annonacin) and alkaloids (e.g., coreximine
and reticuline) found in different Annonaceae plants such as Annona muricata (Lannuzel et al.,
2002; Potts et al., 2012). Annonacin, the most abundant acetogenin in A. muricata, has been shown
to cause neuronal loss and accumulation of phosphorylated tau protein in cultured neurons
(Escobar-Khondiker et al., 2007; Hollerhage et al., 2009).
Some isoquinoline alkaloids, obtained from various species of Annonaceae, show
dopamine receptor antagonistic activity as well as neuronal cell death (Zhang et al., 2007). The
potential risks of neurodegeneration associated with chronic consumption of the fruits and leaves
from Annonaceae plants emphasized the need for further studies to determine and identify the
neurotoxic compounds in these edible plants and compare their risk to their benefits in defeating
cancer.
The present investigation is focused on Asimina triloba, commonly known as pawpaw.
This is one of the Annonaceae plant species that is attributed to treating cancer, and its extract has
been found to be the most potent of 3,500 species of higher plants screened for bioactive
compounds (McLaughlin, 2008). It is native to North America, and it is the only species of
Annonaceae with edible fruits that grows in the temperate regions. Pawpaw and many other plants
of this species are consumed either as fresh fruits or processed into ice creams, juices, liquors, and
many other products. It is also currently marketed as a dietary supplement for its potential use in
alternative cancer treatment (Coothankandaswamy et al., 2010).
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This study was carried out to explore the cytotoxic and neurotoxic constituents of the plant
with the intention that separating the neurotoxic constituents would help in reducing the
adverse/undesirable effects of the plant if it is used as an alternative therapy. Although much effort
has been directed in the past towards the acetogenins constituents, and it has been well-established
that cytotoxic potential of this plant is due to the presence of acetogenins. However, the alkaloidal
constituents of Asimina triloba have not been explored in terms of cytotoxicity and neurotoxicity.
Therefore, we focused on determining the cytotoxicity and neurotoxicity of three different extracts
of A. triloba: a crude methanolic extract (MeOH), an acetogenin-rich extract (ACG), and the
alkaloid-rich extract (ALK). Additionally, we explored six alkaloids isolated from ALK extract to
understand how the presence and the absence of the alkaloids and acetogenins will affect the
biological properties of this plant.

2. Materials and methods
2.1. Plant material
The three extracts (MeOH extract, ALK extract, and ACG extract) were prepared as
reported before (Majrashi et al., 2018). Briefly, the plant material was extracted with methanol and
then subjected to the acid-base alkaloidal extraction. In brief, the MeOH extract was suspended in
2% HCl and extracted with ethyl acetate (EtOAc). After separating the EtOAc layers, the pH of
the resulting aqueous acidic layer was basified with ammonia solution and subsequently extracted
again with EtOAc. The combined EtOAc layers were dried to give an alkaloidal rich extract, which
was fractionated by column chromatography to obtain the pure alkaloids. The structures of the
alkaloids

(anolobine-9-O-β-D-glucopyranoside,

anolobine,

norushinsunine,

liriodenine,

squamolone and coclaurine) isolated from alkaloid rich fraction are shown in Figure 4- 1.
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The identity and purity of these alkaloids were confirmed by chromatographic (TLC, HPLC)
methods and by the analysis of the spectral data (IR, 1D- and 2D-NMR, ESI-HRMS). A detailed
description has been reported by us earlier (Majrashi et al., 2018; Avula et al., 2018).

Figure 4- 1 Chemical structures of alkaloids from Asimina triloba

2.2. Cytotoxicity assay
The cytotoxic activity of the various extracts and pure compounds was determined towards
a panel of four human solid tumor cell lines: melanoma (SK-MEL), epidermal carcinoma (KB),
breast carcinoma (BT-549), and ovarian carcinoma (SK-OV-3). Moreover, non-cancer kidney cell
lines (LLC-PK1 and VERO) were also employed to determine if the anti-cell proliferative activity
of these extracts and compounds was selective for the tested tumor cell lines.
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All cell lines were obtained from the American Type Culture Collection (ATCC, Rockville,
MD). The cells were seeded in 96-well plates (10,000 cells/well) and incubated for 24 h. The three
extracts and six pure alkaloids from Asimina triloba were dissolved in DMSO, diluted in media,
and added to the cells at concentrations of 50, 25, 12.5, 6.25, 3.125 μg/mL. After incubating for
48 hrs, cell viability was determined by using a tetrazolium dye WST-8, which is converted to a
water-soluble formazan product in the presence of 1-methoxy PMS by the activity of cellular
enzymes. The color of the formazan product was measured at 450 nm on a plate reader.
Doxorubicin was used as a positive control for cytotoxicity assay, and DMSO (0.25%) was used
as the vehicle control. The IC50 values were obtained from concentration-response curves. The
values are represented as mean ± standard deviation (n = 3).

2.3. Neurons isolation
Primary cortical neurons were isolated from embryonic day 18-19 Sprague Dawley male
and female rats and were cultured as previously described (Ashpole et al., 2011). Briefly, cortical
cells were dissected and mechanically and enzymatically dissociated with trituration and papain,
respectively. The cells were suspended in a neurobasal media with serum and plated on poly-lysine
coated 24-well or 96-well plates. The total number of neurons used was 125,000 per well. After
24 hours, the media was replaced with neurobasal media supplemented with B27 and penicillin
and streptomycin. The cultured neurons were maintained in an incubator at 37 °C and were treated
following 8–10 days in culture. All experiments were overseen and approved by the University of
Mississippi IACUC (protocol 16-024).
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2.4. Neurotoxicity assay
The neurotoxicity evaluation was performed in 8-10 day old rat cortical neurons. The
extracts and compounds were added to neuronal growth media (neurobasal, B27, penicillin, and
streptomycin) in the following range of concentrations (10, 5, 1, and 0.1 μg/mL) and incubated for
24 hrs. DMSO (0.1%) was used as vehicle control. The MTS assay was used to assess the toxicity
of the extracts and compounds. MTS Aqueous One Solution Reagent was added after incubating
the extracts, compounds, and the control for 24 hrs. Once the MTS was administered to the wells,
the plates were put back into the incubator for 1-2 hrs. The formazan dye produced by viable cells
was quantified by measuring the absorbance at 490 nm. LIVE/DEAD viability stains (Invitrogen)
was used to verify living and cytotoxic cells in a controlled study. Stained cells were quantified by
the Nikon Elements software following image acquisition on the Nikon HCA inverted fluorescent
microscope (100x) in a single field per well, chosen at random by the software.

2.5. Statistical analysis
A one-way ANOVA was used to perform statistical analysis followed by Dunnett’s post hoc
test to examine the significant difference against the control at p<0.05 for each dose of a compound
or extract.

3. Results
3.1. Cytotoxicity
The cytotoxic potential of the three extracts and six alkaloids (Figure 4- 1) was evaluated
in terms of their anti-cell proliferative activities in a panel of cell lines, as shown in Table 4- 1.
Among the three extracts, the acetogenin-rich extract (ACG) showed the most potent anti-
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proliferative activity towards melanoma (SK-MEL), epidermal carcinoma (KB), and breast ductal
carcinoma (BT-549) cells with IC50 values of 0.09, 0.11, and 0.11 µg/mL, respectively. The
extract was equally potent towards both non-cancer kidney cell lines (LLC-PK1 and VERO) with
IC50 values of 0.12 and 0.31 µg/mL. The extract rich in alkaloids (ALK) also showed cytotoxic
activity towards SK-MEL, KB, and BT-549 cells, and the IC50 values were 1.9, 2.6, and 1.7
µg/mL, respectively. The ALK extract was comparatively less toxic (14 X) to VERO cells (IC50
4.25 µg/mL) than the ACG extract. This is the first report of the anti-cell proliferative activity of
the ALK extract from Asimina triloba. Interestingly, the MeOH extract was more potent than ALK
extract towards KB and BT-549 cells (IC50 = 0.6 and 0.55 µg/mL, respectively), but less potent
than ALK extract towards SK-MEL cells (IC50 = 7.1 µg/mL). It was worth noting that MeOH
extract was much less potent than ACG extract towards all the cell lines. Both MeOH and ALK
extracts were much less toxic to VERO cells in comparison to ACG extract. None of the extracts
were effective towards ovarian cancer cells (SK-OV-3), indicating selectivity of cytotoxic
potential among various cancers.
Among the alkaloids, liriodenine was the most effective towards all cancer cells with IC50
of 2.15, 6.3, 9.5, and 4.75 µg/mL for SK-MEL, KB, BT-549, and SK-OV-3 cells, respectively.
Another alkaloid, norushinsunine, also demonstrated activity against all cancer cells with IC50
values in the range of 9.75 – 23 µg/mL. This is the first report of the cytotoxic activity of this
compound. This compound was much less toxic to VERO cells in comparison to liriodenine.
Anolobine-9-O-β-D-glucopyranoside, which is a newly isolated alkaloid from Asimina
triloba (Majrashi et al., 2018), was also effective against SK-MEL and KB cell lines with IC50
values of 31.5 and 47.5 µg/mL. However, the activity was weaker than the other two alkaloids.

57

Anolobine, squamolone, and coclaurine were not active to any of the cancer cells at the highest
tested concentration of 50 µg/mL.

Table 4- 1 Anti-cell proliferative activity of extracts and compounds against a panel of cell
lines.
IC50 µg/mL
Sample Name

MeOH extract

Cancer Cell Lines

SK-MEL

KB

7.1± 1.25

0.6 ± 0.0

ACG extract

0.09 ± 0.01

ALK extract

1.9 ± 0.1

Norushinsunine

16.0 ± 1.0

BT-549

0.55 ±
0.05
0.11 ±
0.11 ±
0.01
0.02
2.6 ± 0.1 1.7 ± 0.3

Non-cancer Kidney Cell
Lines
SK-OV-3

LLC-PK1

Vero

NA

0.2 ± 0.06

19.0 ± 1.0

NA

0.12 ± 0.04

0.31± 0.01

NA

1.5 ± 0.3

4.25 ± 0.25

Squamolone

NA

9.75 ±
2.25
NA

19.5 ±
0.5
NA

23.0 ± 2.0

7.75 ± 0.25

>25

NA

NA

NA

Coclaurine

NA

NA

NA

NA

NA

NA

Anolobine9-O-β-Dglucopyranoside
Anolobine

31.5 ± 6.5

47.5 ±
2.5

>50

>50

NA

NA

NA

NA

>50

NA

NA

NA

Liriodenine

2.15 ± 0.15

6.0 ± 1.0

8.1 ± 0.1

Doxorubicin

1.3 ± 0.5

4.75 ±
1.05
1.7 ± 0.47

0.4 ± 0.56

>5

6.3 ± 0.4 9.5 ± 0.5

1.7 ±
1.4 ±
0.42
0.40
NA= no activity at the highest test concentration (50 µg/mL).
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3.2. Neurotoxicity
Among the three extracts of A. triloba, the MeOH extract and ACG extract showed toxicity
to neuronal cells at 10 µg/mL causing a 40% and a 20% decrease in cell viability, respectively
(Figure 4- 2A-B, and 4- 5). The alkaloidal extract was not toxic at the highest tested concentration
of 10 µg/mL but showed a 20% decrease in viability at lower concentrations (Figure 4- 2C). Four
alkaloids,

namely

norushinsunine,

liriodenine,

anolobine,

and

anolobine-9-O-β-D-

glucopyranoside, decreased cell viability significantly at 10 µg/mL, as shown in Figure 4- 5.
Anolobine-9-O-β-D-glucopyranoside demonstrated a strong effect at 1 μg/mL, and no further
reduction in cell viability was noticed with higher concentrations of 5 and 10 μg/mL, as shown in
Figure 4- 3A.
However, Anolobine (the aglycone) was less effective in reducing cell viability of neuronal
cells (Figure 4- 3B). Norushinsunine exhibited significant toxicity at 10 μg/mL (Figure 4- 4A).
On the other hand, Liriodenine demonstrated a dose-dependent reduction in the cell viability in
the concentration range of 1 – 10 µg/mL, as shown in Figure 4- 4B. Coclaurine and squamolone
did not show a significant decrease in cell viability (Figure 4- 3C and 4C). To summarize the
data, all of the extracts and alkaloids were combined in a bar graph to display their effects at the
highest tested concentration of 10 μg/mL (Figure 4- 5).
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Figure 4- 2 Effect of the MeOH extract, ACG extract and ALK extract on neuronal cell viability.
MeOH extract (A) and ACG extract (B) showed a significant concentration-dependent decrease in
cell viability. ALK (C) extract did not show a significant reduction in cell viability with the
increasing concentrations.
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Figure 4- 3 Effect of anolobine-9-O-β-D-glucopyranoside, anolobine and coclaurine on neuronal
cell viability.
Anolobine-9-O-β-D-glucopyranoside (A) and Anolobine (B) demonstrated a significant
concentration-dependent reduction in cell viability. Coclaurine (C) did not show a significant
concentration-dependent decrease in cell viability.
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Figure 4- 4 Effect of norushinsunine, liriodenine and squamolone on neuronal cell viability.
Norushinsunine (A) and Liriodenine (B) displayed a significant reduction in cell viability with
increasing concentration. However, Squamolone (C) did not show a significant concentrationdependent decrease in cell viability.
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Figure 4- 5 Effect of Extracts and pure compounds on cell viability at 10 µg/mL. Asterisks
designate statistically significant decreases in cell viability compared to vehicle control.
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4. Discussion
Among all tested extracts, the ACG extract was the most potent in inhibiting cell
proliferation of all cell lines, except SK-OV-3. However, the same extract was found to be
significantly toxic to the neurons as well, which might affect its benefit in treating cancer.
Interestingly, the ALK extract showed cytotoxicity that has not been reported before towards SKMEL, KB, and BT-549 cells with IC50 values in a lower concentration range (1.7-2.6 µg/mL).
Regardless, the toxic effects of some of the pure alkaloids on the neurons, our study showed
that ALK extract did not show a significant decrease in cell viability at 10 µg/mL, which might be
a result of an antagonistic effect of combined alkaloids in which the combination of the alkaloids
shows less effect than the individual compound. Almost all of the previous studies in A.
triloba have focused on the acetogenins and their potential effects in cancer treatment.
Acetogenins from A. triloba have shown different biological activities, including antibacterial,
antifungal, anticancer, and insecticidal effects (Cuendet et al., 2008).
The acetogenins are known for their potent inhibitory effect of mitochondrial (complex I)
and cytoplasmic (anaerobic) production of adenosine triphosphate (ATP), induces tumor cell
apoptosis, programmed cell death (McLaughlin, 2008). Annonacin, an acetogenin with a monotetrahydrofuran ring, has been reported to inhibit the growth estrogen receptor-α (ERα)-positive
breast cancer cell line (MCF-7) (Ko et al., 2011; Yuan et al., 2003). Moreover, many studies have
illustrated the anti-tumor effect of other acetogenins as well such as bullatacin, asimicin, and
trilobacin against various cancers including gastric cancer (Liet al., 2017), colon cancer (Zhao et
al., 1994), prostate cancer and pancreatic cancer (Zhao et al., 1996).
The biological evaluation of the alkaloidal constituents of A. triloba has not been taken into
consideration before. Nonetheless, the alkaloids are one of the most important secondary
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metabolites that are known to possess therapeutic properties that one cannot ignore. Some of the
isoquinoline alkaloids from other Annonaceae plants have been reported for significant anticancer
activities. For example, the oxoaporphine alkaloid liriodenine has manifested cytotoxic effects in
several cancer cell lines, including the adenocarcinoma of the liver (Hsieh et al., 2005), colon
cancer (Chen et al., 2012), and human lung adenocarcinoma (Chang et al., 2004). In our study,
liriodenine illustrated interesting cytotoxicity towards all of the tested cancer cell lines (including
SK-OV-3), with greater activity towards the human melanoma (SK-MEL) cell line with an IC50
of 2.15 μg/mL.
A previous study has reported that squamolone showed significant cytotoxicity towards
hepatocarcinoma cell lines (Hsieh et al., 2001). However, this alkaloid did not display any activity
towards any of the cancer cell lines in our study, indicating specificity for a particular cell line. To
the best of our knowledge, the cytotoxicity and neurotoxicity evaluations of the alkaloidal extract
of A. triloba twigs and the pure alkaloids (anolobine-9-O-β-D-glucopyranoside, anolobine,
norushinsunine, and coclaurine) have not been reported before.
The previous neurotoxicity studies of A. triloba have focused on the neurotoxic acetogenin
(annonacin), which has been found to induce nigral neuron death (Escobar-Khondiker et al., 2007;
Lannuzel et al., 2002; Lannuzel et al., 2003). Furthermore, one study has reported that annonacin
(30.07 μg/mL) and crude EtOAc extract of Asimina triloba fruit pulp (47.96 μg/mL) induced 50%
death of cortical neurons (Potts et al., 2012).

5. Conclusion
Our study highlighted the contribution of the alkaloidal constituents in the neurotoxicity of
A. trilboa. However, our results are not conclusive on the neurotoxicity of A. triloba alkaloids.
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Further studies are warranted, such as addressing the bioavailability of neurotoxic compounds in
vivo. Moreover, the effects of these extracts and compounds on neuronal tumors of the central
nervous system have not been reported. This estimation would be insightful for future studies,
which suggests that the neurotoxic compounds and extracts from A. triloba might be beneficial in
the fight against neuronal-based cancer.
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CHAPTER V

SYNTHESIS OF SOME ALKALOIDS REPORTED FROM ROLLINIA MUCOSA AND
EVALUATION OF THEIR BIOLOGICAL ACTIVITIES

1.

Introduction

Rollinia mucosa is a tropical fruit tree belonging to the Annonaceae family and known as
biriba. Rollinia fruit has been used traditionally in the West Indies and Indonesia for the treatment
of tumors (Hartwell 1982) as well as for nutritious purposes (Shi et al. 1997). In Brazil, the
alkaloidal extract of Rollinia mucosa exhibited antimicrobial and antifungal activities (Caetano
and Dabun, 1987). In Brazil and Peru, the lignans isolated from this species were reported to be
effective in enhancing the toxicity of a wide variety of insecticides (Paulo et al., 1991).
Rollinia mucosa is native to the western Amazon region of Peru and Brazil in South
America. Rollinia mucosa’s seeds from Brazil were sent to the United States and the Philippines
in the early 1900s., and now they are mostly found in Indonesia (Love and Paull 2011). Its chemical
composition and pharmacological activities have been described previously (Caetano and Dabun,
1987; Chen et al. 1996; Liaw et al., 1999; Paulo et al. 1991). This species contains a wide range
of compounds including, acetogenins, aporphine alkaloids, steroids, lignans, tryptamine and fatty
acid derivatives, which have been isolated and identified from different parts of this plant (Chen
et al. 1996; Liaw et al., 1999; Paulo et al. 1991).

67

The phytochemical investigations of the alkaloidal constituents of Rollinia mucosa have
revealed several aporphine alkaloids, including N-methoxycarbonyl aporphines that exhibited
significant inhibition of collagen, arachidonic acid, and platelet activating factor-induced platelet
aggregation (Kuo et al. 2001).
A previous study indicated that Rollinia mucosa fruit pulp has similar neurotoxicity to
graviola, although it has a significantly less amount of the neurotoxic acetogenins that are found
in graviola (Höllerhage et al. 2015). The study highlighted that the neurotoxicity of Rollinia
mucosa fruit could be linked to other not quantified toxins. We hypothesize that the Nmethoxycarbonyl aporphine alkaloids, which have been isolated from Rollinia mucosa, have
cytotoxic effects and may also be responsible for the neurotoxicity that has been reported from the
ethyl acetate extract taking from the fruits and seeds of Rollinia mucosa (Höllerhage et al. 2015).
The cytotoxicity and the neurotoxicity of these alkaloids have not been reported before.
Therefore, our study aims to understand how they contribute to the biological activities of this
plant. (R, S) (±) Romucosine, N-methoxycarbonyl aporphine alkaloid (Chen et al. 1996), and other
relative compounds will be obtained through the total synthesis in order to get a better yield
because this type of alkaloid is usually isolated in meager amounts. That will allow us to gain
enough quantities of the desired compounds that will be subjected to different biological screening,
including cytotoxicity and neurotoxicity, to identify their biological properties and safety. Herein,
we describe the total synthesis of (±) anonaine, 3,4-methylenedioxy-1-phenanthreneethylamine,
(±) romucosine, and [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate by using
direct arylation reactions with 3,4-methylenedioxyphenethylamine 1 and 2-bromophenylacetic
acid 2 in the preparation of these alkaloids.
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We also describe the separation of the enantiomers using different resolution reactions.
Only the resolution with (_)-menthyl chloroformate succeeded in separating the enantiomers, but
we were not able to remove the menthyl chloroformate moiety using different reactions and
conditions. Finally, the presence of the synthesized alkaloids in Rollinia mucosa was studied by
using a targeted analysis of Rollinia mucosa fruits and seeds extracts using UHPLC-QToF-MS.
Moreover, all synthesized compounds were subjected to the biological evaluation in order to
understand how different alkaloid derivatives induced or reduced the cytotoxicity, as well as
neurotoxicity.

2.

Result and Discussion

2.1.

Synthesis

Total synthesis of 6, 7, 8, and 9 was carried out by Bischler-Napieralski reaction (Huang
et al. 2004) with 3,4-methylenedioxyphenethylamine 1, 2-bromophenylacetic acid 2, and an excess
of the reagent POCl3, followed by NaBH4 reduction without further purification due to the air
sensitivity of the produced amine to give compound 3 in 55% yield (Scheme 1). The resulted
tetrahydroisoquinolines 3 was protected with Boc (tert-butyl carbamate group) to produce 4 in
70% yield (Scheme 1), which was subjected to palladium-catalyzed direct intramolecular arylation
of aryl bromides reported before (Lafrance et al. 2007) to afford compound 5 in 64% yield
(Scheme 2). The deprotection of the tert-butyl carbamate group was carried out under acidic
conditions using either TFA or 4M HCL/dioxane (Scheme 2). The deprotection of the amine gives
two products: air sensitive amine, (R, S) (±) anonaine 6, as a minor product in 10% yield, and an
aromatic stabilized new compound 3,4-methylenedioxy-1-phenanthreneethylamine 7 as a major
product in 40% yield.
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Scheme 1. Bischler-Napieralski reaction, and Boc protection reaction.
Reaction conditions: (i) Bischler-Napieralski: POCl3, PhMe, r.t. to 120 °C, 3.5 h. (ii) Reduction:
NaBH4, MeOH, r.t., 2.5 h. (iii) Boc protection: (ROC)2O, DMAP (cat.), iPr2EtN, CH2Cl2.
Overnight, r.t.

Scheme 2. Direct intramolecular arylation, and Boc deprotection.
Reaction conditions: (iv) Pd (OAc)2, ligand (2 equiv. to Pd), K2CO3 (2 equiv.), DMA (0.2 M).
(v) involves two methods: Method A: TFA, DCM, room temp., 1 h. Method B: 4M HCl/dioxane,
0°C, 1 h.
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A mixture of (R, S) (±) anonaine 6 and 3,4-methylenedioxy-1-phenanthreneethylamine 7
was treated with methyl chloroformate (Kohnen et al. 2007) to afford (R, S) (±) romucosine 8 in
70 % yield and another new compound [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]methylcarbamate 9 in 17% yield (Scheme 3). In order to get (R)-anonaine, (S)-anonaine, (R)romucosine, and (S)-romucosine, the racemic mixture of (±) tetrahydroisoquinolines 3 (more
stable than anonaine) was underwent two different resolution reactions to separate the R and S
enantiomers, which are the recycle process of resolution using (+)-dibenzoyl tartaric acid (Shi et
al. 2006), and the resolution with (_)-menthyl chloroformate.

Scheme 3. Preparation of romucosine and [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]methylcarbamate.
Reaction conditions: (vi) ClCO2Me, CH2Cl2, 0 °C.
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The resolution with (+)-dibenzoyl tartaric acid has been reported to be efficient in the
preparation of (R)-(_)-apomorphine and (R)-(_)-aporphine analogs from their racemic mixtures
(Shi et al. 2006). However, we were not able to resolve the racemic compound (±)
tetrahydroisoquinolines 3 using the (+)-dibenzoyl tartaric acid; no salt precipitated was noticed in
several solvents tried. On the other hand, the resolution with (_)-menthyl chloroformate succeeded
in separating the enantiomers (Scheme 4). The treatment of (±) tetrahydroisoquinolines 3 with (_)menthyl chloroformate selectively gives diastereomeric carbamates that are resolvable on the
normal phase column chromatography. The optical rotation analysis revealed [α]25D _ 47 (c = 0.3,
CHCl3) for (_) tetrahydroisoquinolines 10, and [α]25D + 42 (c = 0.28, CHCl3) for (+)
tetrahydroisoquinolines 11, which prove the successful separation of the enantiomers. However,
the cleavage of the carbamates in compounds 10 and 11 was challenging.

Scheme 4. The enantiomers resolution of 3 with (-) (1R)-menthyl chloroformate.
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Different reactions and conditions were performed to remove the menthyl moiety after the
enantiomeric separation, and none of them have worked. Treatment of 10 and 11 with 4M
HCl/dioxane at 0 °C for 3 hrs, then at r.t for overnight afforded unreacted starting martial with
many other spots on the TLC. The use of different concentrations of TFA in dichloromethane at
r.t. for 48 hrs afforded unreacted starting martial as well with other impurities. Also, the attempted
hydrolysis of menthyl carbamates in a pressure glass container at 110 °C in TFA for 6 hrs and
basify with 10 M sodium hydroxide solution led to the disappearance of starting martial, but the
desired product was not detected. The hydrolysis with 5M lithium hydroxide or 5M sodium
hydroxide in THF at r.t. for 2 hrs, then by heating (60 °C) under reflux for overnight afforded
unreacted starting martial with other impurities. Finally, the treatment of 10 and 11 with LiAlH4
in dry THF at r.t. for 24 hrs afforded only recovered starting material.

2.2.

ESI-QToF-MS of reference standards

Compounds 6-9 were analyzed using LC-ESI-QToF-MS to find the specificity of MS-MS
spectral patterns based on their structures (Table 5- 1). Compounds 6 and 7 chromatographic peaks
contained the same protonated molecules in the MS spectra ([M+H]+ 266.1176) and similar
product ions in MS/MS spectra (191.0850) but had different retention behaviors (6.03 min and
6.6min for compounds 6 and 7; respectively). Similarly, compounds 8 and 9 showed the same
protonated molecules in the MS spectra (([M+H]+ 324.123) and similar product ions in MS/MS
spectra (249.0926) with different retention behaviors (10.85 min and 10.25 for compounds 8 and
9; respectively).
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Table 5- 1 Accurate mass data, fragment ions for compounds 6-9 using UHPLC Q-ToF.
Sample name

Rt (min)

Molecular Formula

[M+H]+

Fragments

Compound 6

6.03

C17H15NO2

266.1176

191.0850

Compound 7

6.6

C17H13NO2

266.1176

249.0876, 191.0866

Compound 8

10.85

C19H17NO4

324.123

249.0898, 191.0840

Compound 9

10.25

C19H15NO4

324.123

249.0926

2.3.

Targeted analysis of Rollinia mucosa using UHPLC-QToF-MS

The high chromatographic resolution and separation capabilities of the UHPLC with
QToF-MS have been applied to the identification and characterization of synthesized alkaloids
(compound 6-9) (Table 5- 2). Three of the standard compounds (compound 7-9) were not detected
from methanolic extracts (RMFM and RMSM) or the alkaloidal extracts of the fruits and seeds of
Rollinia mucosa. Anonaine (compound 6) is the only compound that was detected from methanolic
extract (RMSM) and alkaloidal extract (ALK-S) of the seeds, and a tiny amount was also detected
in the fruits methanolic extract (RMFM) (Table 5- 2).
The presence of anonaine in Rollinia mucosa extracts was identified by comparing the
retention time and the MS and MS/MS data with a reference standard (compound 6). Anonaine
and romucosine (compound 9) have been reported previously from the fruits of Rollinia mucosa
(Chen et al., 1996). Herein, we confirm the presence of anonaine in the Rollinia mucosa fruits and
seeds (Table 5- 2).
However, we were not able to detect the presence of romucosine (compound 9) in Rollinia
mucosa fruits or seeds, which indicate that romucosine would be an artifact formed during the
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acid-base extraction of alkaloids. Therefore, it is not clear whether the N-(methoxycarbonyl)
alkaloids isolated from Rollinia mucosa earlier (Chen et al., 1996; Kuo et al., 2001; Kuo et al.,
2004) are “natural products” or artifacts formed during the alkaloidal extraction process. The use
of conventional acid-base extraction to isolate the N-(methoxycarbonyl) alkaloids from Rollinia
mucosa should be revised because it can lead to the formation of artifacts (Maltese et al., 2009). It
is also possible that Rollinia mucosa species have several subspecies or chemotypes, which might
produce different types of compounds, including the N-(methoxycarbonyl) alkaloids.

Table 5- 2 Targeted analysis of R. mucosa fruits and seeds extracts using UHPLC-QToF-MS
#

Sample

Compound 6

Compound 7

Compound 8

Compound 9

6.03

6.6

10.85

10.25

m/z

266.1176

266.1176

324.123

324.123

1

RMFM

Tiny (t)

ND

ND

ND

2

RMSM

+

ND

ND

ND

3

ALK-F

ND

ND

ND

ND

4

ALK-S

+

ND

ND

ND

Rt
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2.4.

Anticancer

The anticancer potential of the synthesized alkaloids (Figure 5-1) and extracts was
evaluated in terms of their anti-cell proliferative activities in a panel of cancer cell lines, as shown
in Table 5- 3 and Table 5- 4.

Figure 5- 1 Synthesized alkaloids from Rollinia mucosa

Anonaine (compound 6) was effective towards all cancer cells with IC50 of 5.9, 18.5, 16.0,
and 10.5 µg/mL for SK-MEL, KB, BT-549, and SK-OV-3 cells, respectively. 3, 4Methylenedioxy-1-phenanthreneethylamine (compound 7) was also effective towards all cancer
cells and was more effective than anonaine towards KB, and SK-OV-3 cells with IC50 of 11.5 and
8.9 µg/mL, and it has almost similar activities to anonaine towards BT-549 with IC50 of 17.5
µg/mL.
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3, 4-Methylenedioxy-1-phenanthreneethylamine was less active than anonaine towards
SK-MEL with IC50 of 11.5 µg/mL. Moreover, 3, 4-methylenedioxy-1-phenanthreneethylamine
was less toxic to LLC-PK1 and VERO cells in comparison to anonaine. Romucosine (compound
8) demonstrated selective anticancer activities towards SK-MEL with IC50 of 15.2 µg/mL. [2-(3,
4-methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate (compound 9)

also has selective

activities towards SK-MEL and SK-OV-3 with IC50 of 18.5 and 17.5 µg/mL. Romucosine and [2(3,4-methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate were not toxic towards LLC-PK1
and VERO cells comparing to anonaine and 3, 4-Methylenedioxy-1-phenanthreneethylamine, as
shown in Table 5- 3.

Table 5- 3 Anti-cell proliferative effects of compounds 6-9.
SK-MEL

KB

BT-549

SK-OV-3

LLC-PK1

Vero

IC50
µg/mL
5.9 ± 0.4

IC50
µg/mL
18.5 ± 1.5

IC50
µg/mL
16.0 ± 1.0

IC50
µg/mL
10.5 ± 0.5

IC50
µg/mL
9.2 ± 0.7

IC50
µg/mL
9.0 ± 1.0

Compound (7) 11.5 ± 0.5

11.5 ± 0.5

17.5 ± 0.5

8.9 ± 0.2

11.5 ± 0.5

16.5 ± 0.5

Compound (8) 15.2 ± 2.7

43.0 ± 7.0

29.0 ± 1.0

32.5 ± 2.5

46.5 ± 1.5

50.0 ± 0.0

Compound (9) 18.5 ± 0.5

28.0 ± 4.0

37.0 ± 2.0

17.5 ± 0.5

32.5 ± 7.5

29.5 ± 0.5

Doxorubicin

1.1 ± 0.1

1.3 ± 0.1

0.9 ± 0.2

0.8 ±0.02

>5

Sample Code

Compound (6)

0.7 ± 0.0
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Several studies have been conducted on the anticancer activities of (-) anonaine on different
cancer cell lines including a study reported that (-) anonaine showed a significant cytotoxic effect
against three cell cultures (rat hepatocytes, HepG2 and HeLa) with IC50 values of 70.3, 33.5, and
24.8 μg/mL, respectively (Correché et al., 2008). Another study has indicated that (-) anonaine
displayed significant cytotoxicity against AGS (human gastric cancer cell), DLD1 (human colon
cancer cell), HA59T (human hepatoma cell), and HepG2 (human hepatoma cell) cancer cell lines
with AGS cells being the most susceptible (Chen et al., 2000). Also, it was reported to cause DNA
damage associated with increased intracellular nitric oxide, ROS, glutathione (GSH) depletion,
disruptive mitochondrial transmembrane potential, activation caspase 3, 7, 8 & 9 and poly ADP
ribose polymerase cleavage in human cervical cancer cell (HeLa) (Chen et al., 2008).
Herein, we reported that anonaine showed a significant effect in all cancer cell lines tested
in this study with IC50 range 5.9-18.5 µg/mL. Romucosine has been tested before on three cancer
cell lines, Human MCF-7 cells (breast cancer), NCI-H460 cells (lung cancer), and SF-268 cells
(central nervous cancer), and it showed no cytotoxic activities (Liu et al., 2008). In our study,
romucosine displayed selective anticancer activities toward SK-MEL 15.2 µg/mL. 3, 4Methylenedioxy-1-phenanthreneethylamine and [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]methylcarbamate are new compounds that have not synthesized or isolated previously. The
anticancer

activities

of

3,

4-methylenedioxy-1-phenanthreneethylamine

and

[2-(3,4-

methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate have not been reported before, and our
study indicated interesting anticancer activities of these compounds.
Rollinia mucosa fruits extracts (RMFM, Non-ALK-F, and ALK-F) and seeds extracts
(RMSM, Non-ALK-S, and ALK-S) anti-cell proliferative results are shown in Table 5- 4.
Surprisingly, all extracts are toxic to all cancer cell lines with very low concentrations. The extent
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of toxicity to KB cells is very similar to LLCPK1 cells for all the extracts. Furthermore, the extracts
are more toxic to SKMEL, BT-549, and SK-OV3 cells compared to KB and LLCPK1 cells. The
toxicity to Vero cells is lower compared to the other cell lines included in the assay. This pattern
is similar to Doxorubicin. In general, seed extracts are more toxic than the fruit extracts toward all
cell lines. These findings are conflicting with neurotoxicity results, which showed that all extracts
(except ALK-S) are not toxic to the neurons up to 20 µg/mL. However, we would suggest that
these extracts cause extreme toxicities to the cancer cell lines and the non-cancer kidney cell lines
due to their ability to penetrate those cells but not able to penetrate the neuron cells. Therefore,
further future studies are needed to understand these results.

Table 5- 4 Anti-cell proliferative activity of Rollinia mucosa extracts against a panel of cell lines.
Non-cancer Kidney
Cancer Cell Lines

Cell Lines

SK-MEL

KB

BT-549

SK-OV-3

LLC-PK1

Vero

IC50

IC50

IC50

IC50

IC50

IC50

µg/mL

µg/mL

µg/mL

µg/mL

µg/mL

µg/mL

RMFM

0.027

0.092

0.03

0.034

0.09

0.35

RMSM

<0.016

<0.016

<0.016

<0.016

<0.016

0.038

Non-ALK-F

0.026

0.088

0.037

0.038

0.096

0.37

Non-ALK-S

<0.016

<0.016

<0.016

<0.016

<0.016

0.033

ALK-F

0.075

0.2

0.092

0.088

0.2

>0.5

ALK-S

<0.016

<0.016

<0.016

<0.016

<0.016

0.16

Doxorubicin

0.5

0.6

0.72

0.34

0.3

>5

Sample Code
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2.5.

Neurotoxicity

Among the six extracts (RMSM, non-ALK-S, ALK-S, RMFM, non-ALK-F, and ALK-F),
the alkaloidal extract from the seeds of Rollinia mucosa (ALK-S) showed a significant dosedependent decrease in cell viability at 10 and 20 μg/mL (Fig. 5- 2C). All other extracts (RMSM,
non-ALK-S, RMFM, non-ALK-F, and ALK-F) were not toxic at the highest tested concentration
of 20 µg/mL (Fig. 5- 2A-B and Fig. 5- 3A-C). The alkaloid anonaine (compound 6) exhibited
significant toxicity at 5 μg/mL, and no further reduction in cell viability was noticed with higher
concentrations of 10 and 20 μg/mL, as shown in Fig 5- 4A.
The rest of the alkaloids [3, 4-methylenedioxy-1-phenanthreneethylamine (compound 7),
romucosine (compound 8), and [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate
(compound 9)] did not show a significant decrease in cell viability (Fig. 5- 4B-D). To summarize
the data, all of the extracts and alkaloids were combined in a bar graph to display their effects at
the highest tested concentration of 20 μg/mL (Fig. 5- 5).
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Figure 5- 2 Effect of RMSM, Non-ALK-S, and ALK-S extracts on neuronal cell viability.
A) MeOH extract (RMSM) and B) non-alkaloid seeds extract (Non-ALK-S) from the seeds of
Rollinia mucosa did not show a significant reduction in cell viability with the increasing
concentrations. C) The alkaloid extract (ALK-S) showed a significant concentration-dependent
decrease in cell viability.
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Figure 5- 3 Effect of RMFM, Non-ALK-F, and ALK-F extracts on neuronal cell viability.
All of the three extracts [MeOH extract (RMFM), non-alkaloid extract (Non-ALK-F) and
alkaloid extract (ALK-F)] of Rollinia mucosa’s fruits did not show a significant concentrationdependent decrease in cell viability.
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Figure 5- 4 Effect of compounds 6-9 on neuronal cell viability.
A) Anonaine (Compound 6) demonstrated a significant reduction in cell viability at 5 μg/mL. B),
C), and D) Compounds 7-9 did not show a significant concentration-dependent decrease in cell
viability.
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Figure 5- 5 Effect of extracts and synthesized compounds 6-9 on cell viability at 20 µg/mL.
Asterisks designate statistically significant decreases in cell viability compared to vehicle
control.
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3.

Materials and methods

3.1.

General experimental procedures of the synthesis

Reactions were performed under argon atmosphere in oven-dried glassware with magnetic
stirring. Solvents were distilled under an argon atmosphere before use. All reagents obtained
commercially were used without further purification. The reaction progress was monitored on
aluminum-backed plates, pre-coated with silica gel F254 (200 μm, 60 Å, (Merck) thin-layer
chromatography (TLC) plates. Spots were detected at UV-254 nm. Visualization was attained by
dipping the TLC plate into a solution of phosphomolybdic acid (PMA), 10 g of phosphomolybdic
acid in 100 mL of absolute ethanol, followed by heating with a heat gun. Column chromatography
was carried out using flash silica gel (40 μm, 60 Å, J. T. Baker). NMR spectra were obtained on
Bruker AU III 400 or 500 MHz NMR spectrometers using, CD3OD or CDCl3 solvents. IR spectra
were recorded on an Agilent Technologies Cary 630 FTIR. Rudolph Research Analytical Autopol
IV automatic polarimeter was used to obtain the specific rotations. High-resolution mass spectra
were recorded on an Agilent electrospray ionization quadrupole time-of-flight (ESI-QTOF)
instrument.

3.2. Ultra-High-Performance Liquid Chromatography-Quadrupole Time of Flight-Mass
Spectrometry (UHPLC/QToF-MS)
The liquid chromatographic system was an Agilent Series 1290 comprised of the following
modular components: binary pump, a vacuum solvent microdegasser, an autosampler with a 100well tray, and a thermostatically controlled column compartment. The separation was achieved on
an Agilent Poroshell 120 EC-18 (2.1×100 mm, 2.7 µ) column.
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The mobile phase consisted of water with 0.1% formic acid (A) and acetonitrile with 0.1%
formic acid (B) at a flow rate of 0.23 mL/min, with the following gradient: 0 min, 2% B in next
20 min to 10% B, for next 30 min 20% B, for next 20 min 50% B, for next 20 min 70% B, for next
20 min 90% B and to 100% B in next 10 min. Each run was followed by a 5 min wash with 100%
B and an equilibration period of 5 min with 2% B. Two microliters of sample were injected.
The column temperature was set at 40 °C, and UV spectra were recorded from 190-400
nm. The mass spectrometric analysis was performed with a QToF-MS/MS (Model #G6530A,
Agilent Technologies, Palo Alto, CA, USA) equipped with an ESI source with Jet Stream
technology using the following parameters: drying gas (N2) flow rate, 8.0 L/min; drying gas
temperature, 300 °C; nebulizer, 27 psig, sheath gas temperature, 300 °C; sheath gas flow, 8.0
L/min; capillary, 3500V; skimmer, 65V; Oct RF V, 750V; fragmentor voltage, 100V. The sample
collision energy was set at 55eV. All the operations' acquisition and analysis of data were
controlled by Agilent MassHunter Acquisition Software Ver. A.05.00 and processed with
MassHunter Qualitative Analysis software Ver. B.07.00. Each sample was analyzed in a positive
mode in the range of m/z = 100-1700.
Accurate mass measurements were obtained using ion correction techniques using
reference masses at m/z 121.0509 (protonated purine) and 922.0098 [protonated hexakis (1H, 1H,
3H-tetrafluoropropoxy) phosphazine or HP-921] in positive ion mode. The compounds were
confirmed in each spectrum. For this purpose, the reference solution was introduced into the ESI
source via a T-junction using an Agilent Series 1200 isocratic pump (Agilent Technologies, Santa
Clara, CA, USA) using a 100:1 splitter set at a flow rate of 20 µL/min.
For recording ToF-MS spectra, the quadrupole was set to pass all ions (Rf only mode), and
all ions were transmitted into the pusher region of the time-of-flight analyzer where they were

86

mass-analyzed with a 1 s integration time up to m/z 1000. For the ESI-MS/MS CID experiments,
ions of interest were mass-selected by the quadrupole mass filter. The selected ions then collided
with nitrogen in a high-pressure collision cell, and the collision energy was optimized to afford
good product ion signals that were subsequently mass measured with the ToF analyzer.
The analysis was performed in the reflectron mode with a resolving power of about 10,000
at m/z 922. The instrument was set to an extended dynamic range (up to 105 with lower resolving
power). MS/MS spectra were recorded simultaneously at a rate of 2.0 spectra s−1. In order to filter
selected precursor ions and their isotopes for MS/MS, an isolation window of 1.3 m/z was set for
the quadrupole.

3.3.

Mass Data analysis

MassHunter Workstation software, including Qualitative Analysis (version B.07.00), was
used for processing both raw MS and MS/MS data, including molecular feature extraction,
background subtraction, data filtering, and molecular formula estimation (using accurate mass of
all isotopes, their relative abundances, and all detected adducts with their measured isotopes). To
perform subtraction of molecular features (MFs) originating from the background, analysis of a
blank sample (methanol) was carried out under identical instrument settings, and background MFs
were removed. This method involved the use of the [M+H]+ and [M+Na]+ ions in the positive ion
mode, found in the extracted ion chromatogram (EIC).
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3.4.

Plant Material

Rollinia mucosa fruits and seeds methanol extract were received from Dr. Yang-Chang
Wu, Chair Professor Graduate Institute of Integrated Medicine Director (Chinese Medicine R&D
Center (CMUH), China Medical University).

3.5.

Alkaloids extraction

Dried Rollinia mucosa fruits (212.128 g) and seeds (67.374 g) were finely powdered and
extracted separately with methanol to obtain (6.603 g) of fruit extract (RMFM) and (5.776 g) of
seeds extract (RMSM). An aliquot of MeOH extract (1.250 g of fruits and 1.380 of seeds) was
subjected separately to the acid-base alkaloidal extraction. The extract was suspended in 3% HCl
(75 mL) and extracted with CHCl3 (3 × 75 mL) in a separating funnel. After separating the CHCl3
layers, the resulting aqueous acidic layer’s pH was adjusted to 9−10 with ammonia solution and
subsequently extracted again with CHCl3 (3 × 75 mL). The combined CHCl3 layers from the
basified solution were dried to give an alkaloidal extract (19 mg) from fruit extract (ALK-F) and
(7 mg) from seeds extract (ALK-S).

3.6.

Anticancer assay

The anticancer activity of the various extracts and pure compounds was determined
towards a panel of four human solid tumor cell lines: melanoma (SK-MEL), epidermal carcinoma
(KB), breast carcinoma (BT-549), and ovarian carcinoma (SK-OV-3). Moreover, non-cancer
kidney cell lines (LLC-PK1 and VERO) were also employed to determine if the anti-cell
proliferative activity of these extracts and compounds was selective for the tested tumor cell lines.
All cell lines were obtained from the American Type Culture Collection (ATCC, Rockville, MD).
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The cells were seeded in 96-well plates (10,000 cells/well) and incubated for 24 h. The
extracts and pure alkaloids were dissolved in DMSO, diluted in media, and added to the cells at
concentrations of 50, 25, 12.5, 6.25, 3.125 μg/mL. After incubating for 48 hrs, cell viability was
determined by using a tetrazolium dye WST-8, which is converted to a water-soluble formazan
product in the presence of 1-methoxy PMS by the activity of cellular enzymes. The color of the
formazan product was measured at 450 nm on a plate reader. Doxorubicin was used as a positive
control for anticancer assay, and DMSO (0.25%) was used as the vehicle control. The IC 50 values
were obtained from concentration-response curves. The values are represented as mean ± average
deviation (n = 2).

3.7.

Neurotoxicity assay

The neurotoxicity evaluation was performed in 8-10 day old rat cortical neurons. The
extracts and compounds were added to neuronal growth media (neurobasal, B27, penicillin, and
streptomycin) in the following range of concentrations (10, 5, 1, and 0.1 μg/mL) and incubated for
24 hrs. DMSO (0.1%) was used as vehicle control. The MTS assay was used to assess the toxicity
of the extracts and compounds. MTS Aqueous One Solution Reagent was added after incubating
the extracts, compounds, and the control for 24 hrs. Once the MTS was administered to the wells,
the plates were put back into the incubator for 1-2 hrs. The formazan dye produced by viable cells
was quantified by measuring the absorbance at 490 nm. LIVE/DEAD viability stains (Invitrogen)
were used to verify living and cytotoxic cells in a controlled study. Stained cells were quantified
by the Nikon Elements software following image acquisition on the Nikon HCA inverted
fluorescent microscope (100x) in a single field per well, chosen at random by the software.
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3.8.

Statistical analysis

A one-way ANOVA was used to perform statistical analysis followed by Dunnett’s post
hoc test to examine the significant difference against the control at p<0.05 for each dose of a
compound or extract.

4.

Experimental

4.1.

Synthesis of compounds 3-9

5-(2-Bromobenzyl)-5,6,7,8-tetrahydro[1,3dioxolo[4,5-g]isoquinoline (3):
To

a

mixture

of

2-bromophenylacetic

acid

(10.00

mmol)

and

3,4-

methylenedioxyphenethylamine (1.81 g, 10.00 mmol), POCl3 (4 ml, 43.92 mmol) was added
dropwise. After 1 h stirring at r.t., toluene (10 ml) was added and the mixture heated under reflux
for 3.5 h. Then the mixture was evaporated, the residue dissolved in MeOH (5 ml), and the soln.
poured into ice. The aq. phase was basified with 25% NH4OH soln. and extracted with CH2Cl2 (3x
50 ml), the combined org. phase washed with H2O (100 ml), dried (Na2SO4), and evaporated, and
the residue dissolved in MeOH (30 ml). To this soln., NaBH 4 (946 mg, 25.00 mmol) was added
portion-wise for 30 min while stirring. After 24 h, the soln. was evaporated, the residue suspended
in CH2Cl2 (50 ml) and washed with H2O (50 ml), the org. phase dried (Na2SO4), evaporated (2.00
g), and (1.00 g) of the residue purified by CC (Al2O3) using [hexane: EtOAc (9:1), hexane: EtOAc
(8:2), hexane: EtOAc (7:3), hexane: EtOAc (6:4), and EtOAc. The product didn’t come out with
all of the solvent systems mentioned above; therefore, we used acetone: H 2O (9:1) to afford 500
mg white crystal of compound 3.
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1H

(400 MHz, DMSO-d6): δ = 2.90 (dt, J =16.8, 6.01 Hz, 1 H), 3.12 (dt, J = 16.5, 6.04 Hz,

1 H), 3.16–3.25 (m, 1 H), 3.38–3.5 (m, 3 H), 4.65 (t, J = 7.25 Hz, 1 H), 5.97 (d, J = 1.32 Hz, 1 H),
5.99 (d, J = 1.2 Hz, 1 H), 6.45 (d, J =1.38 Hz, 1 H), 6.83 (d, J =1.38 Hz, 1 H), 7.28 (tt, J = 7.58,
1.66 Hz, 1 H), 7.39 (tt, J = 7.47, 1.45 Hz, 1 H), 7.58 (dt, J = 7.62, 1.65 Hz, 1 H), 7.68 (dt, J = 7.94,
1.43 Hz, 1 H) ppm.
13C

NMR (100 MHz, DMSO-d6): δ = 25.3, 39.06, 39.9, 54.1, 101.5, 106.6, 108.9, 125.14,

125.16, 126.5, 128.5, 129.9, 133.1, 133.3, 135.6, 146.3, 147.3 ppm. HRESI-MS calcd. for
[C17H16BrNO2 +H] (M++H): 346.044; found: 346.051.

tert-Butyl 5-(2-Bromobenzyl)-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline-6(5H)-carboxylate
(4):
To

a

solution

of

the

bromo-tetrahydrobenzylisoquinoline

(3)

(1.0

equiv.),

diisopropylethylamine (3.0 equiv.) and 1–3 mg of 4-(dimethylamino) pyridine in DCM (0.2 M)
was added slowly di-tert-butyl dicarbonate (2.0 equiv.) and the resulting mixture was stirred
overnight at 23 °C. The reaction was then quenched by adding a solution of NH4Cl and was
extracted with DCM. The crude reaction mixture was then purified by column chromatography on
silica gel using hexane/ EtOAc mixtures to afford 0.7 g of (4).
1H

NMR and 13C NMR analysis revealed the presence of two amide rotamers present in a

4:1 ratio.1H NMR (400 MHz, CDCl3, major rotamer): δ = 1.10 (s, 9 H), 2.66 (ddd, J = 16.16, 4.28,
2.14 Hz, 1 H), 2.86–2.94 (m, 1 H), 2.98 (dd, J = 13.83, 11.13 Hz, 1 H), 3.29 (ddd, J = 13.85, 9.64,
3.65 Hz, 2 H), 4.32–4.42 (m, 1 H), 5.38 (dd, J = 11.11, 3.13 Hz, 1 H), 5.94 (d, J = 1.45 Hz, 1H),
5.95 (d, J = 1.40 Hz, 1H), 6.62 (s, 1 H), 6.90 (s, 1 H), 7.10 (dd, J =7.46, 1.81 Hz, 1 H), 7.15 (td, J
= 7.66, 1.8 Hz, 1 H), 7.24 (m, 1 H), 7.59 (dd, J = 7.95, 1.28 Hz, 1 H).
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13C

NMR (100 MHz, CDCl3, major rotamer): δ = 27.8, 28.6, 36.1, 42.7, 53.9, 79.4, 100.9,

106.8, 108.6, 125.3, 127.4, 127.6, 128.2, 130.2, 131.8, 132.5, 138.1, 146.1, 146.4, 154.1 ppm.
HRESI-MS calcd. for [C17H16BrNO2+CH3OH+H] (M++CH3OH+H): 478.1229; found 478.1085.

tert-Butyl 5,6,7a,8-Tetrahydrobenzo[g][1,3]dioxolo[4’,5’:4,5]-benzo[1,2,3-de]quinoline-7carboxylate (5):
General Procedure for the intramolecular direct arylation.
To (0.3g, 1 equiv.) of the aryl halide (4) in a round-bottomed flask with a magnetic stir bar,
K2CO3 (2 equiv.), ligand (Di-tert-butyl(methyl)phosphonium tetrafluoroborate) (0.1 equiv.), and
Pd(OAc)2 (0.05 equiv.) were added. The flask is purged with argon. Anhydrous DMA (N,Ndimethylacetamide) is then added (0.2 M), and the resulting mixture is heated to 130 °C overnight.
The reaction mixture is then concentrated and loaded onto a silica gel column for chromatography
using hexane/EtOAc mixtures to afford 0.193g of (5).
1H

NMR (400 MHz, CDCl3): δ = 1.53 (s, 9 H), 2.63 (dt, J = 15.4, 2.25 Hz, 1 H), 2.79 –

2.98 (m, 3 H), 3.06 (dd, J = 13.8, 4.3 Hz, 1 H), 4.42 (d, J = 12.4 Hz, 1 H), 4.83 (d, J = 12.8 Hz, 1
H), 5.98 (d, J = 1.41 Hz, 1 H), 6.11 (d, J = 1.4 Hz, 1 H), 6.62 (s, 1 H), 7.24–7.36 (m, 3 H), 8.13 (d,
J = 7.66 Hz, 1 H) ppm.
13C

NMR (100 MHz, CDCl3): δ = 28.5, 29.7, 30.4, 34.9, 51.6, 79.9, 100.8, 107.5, 117.2,

126.0, 126.9, 126.9, 127.0, 127.7, 127.9, 128.4, 130.7, 136.0, 142.9, 146.7, 154.5 ppm. HRESIMS calcd. for [C17H15NO2] (M+): 365.1627; found: 365.2474.
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6,7,7a,8-tetrahydro-5H-[1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]benzo[g]quinoline [(±)Anonaine
(6)], and 6,7-dihydro-5H-[1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]benzo[g]quinoline [3,4methylenedioxy-1-phenanthreneethylamine (7)]:
Method A:
Trifluoroacetic acid (0.34 mL, 13.0 equiv.) was added dropwise to a solution of (5) (0.122
g, 1.0 equiv.) in dichloromethane (3 mL) and the resulting mixture was stirred at room temperature
for 1 h. The solution was removed under reduced pressure, and saturated NaHCO3 was added to
the residue. The mixture was extracted with EtOAc, dried with MgSO 4, filtered, evaporated and
then purified by chromatography on column using hexane/EtOAc mixture as the eluent to afford
10 mg of (±) anonaine 6 and 40 mg of 3, 4-methylenedioxy-1-phenanthreneethylamine 7.
Method B:
A solution of 4M HCl/dioxane was added to the carbamate (5) in a round-bottom flask with a
magnetic stir-bar at 0 °C. The reaction was completed within 45 mins. TLC indicated the formation
of (±) anonaine 6 and 3,4-methylenedioxy-1-phenanthreneethylamine 7. Then, the solvent was
removed by rotary evaporation under high vacuum at room temperature to afford a mixture of 6
and 7 in a salt form that was stored without further purification for the preparation of compounds
8 and 9.
1H

NMR for (±)Anonaine 6 (400 MHz, CD3OD): δ = 2.66–2.74 (m, 1 H), 2.79 (t, J = 14.16

Hz, 1 H), 2.95–3.11 (m, 3 H), 3.35–3.49 (m, 1 H), 3.96 (dd, J = 14.05, 4.91 Hz, 1 H), 5.91 (d, J =
1.14 Hz, 1 H), 6.06 (d, J = 1.17 Hz, 1 H), 6.59 (s, 1 H), 7.20–7.32 (m, 3 H), 8.13 (d, J = 7.64 Hz,
1 H) ppm.
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13C

NMR (100 MHz, CD3OD): δ = 27.1, 34.9, 42.1, 52.9, 100.8, 107.3, 109.9, 115.7,

125.0, 125.6, 126.8, 127.4, 127.7, 130.6, 133.8, 142.7, 147.5 ppm. HRESI-MS calcd. for
[C17H15NO2 +H] (M++H) 266.118; found: 266.122.
1H

NMR for 3,4-methylenedioxy-1-phenanthreneethylamine 7 (500 MHz, CD3OD): δ =

3.24 (dd, J = 9.33, 6.51 Hz, 2 H), 3.41 (dd, J = 9.14, 6.72 Hz, 2 H), 6.25 (s, 2H), 7.22 (s, 1 H), 7.60
(dt, J = 6.22, 3.52 Hz, 2 H), 7.66 (d, J = 9.27 Hz, 1H), 7.80–7.92 (m, 2 H), 9.06 (dd, J = 6.09, 3.45
Hz, 1 H) ppm.
13C

NMR (125 MHz, CD3OD): δ = 30.8, 40.2, 101.3, 110.5, 116.8, 121.6, 125.4, 125.8,

126.0, 126.6, 126.9, 127.0, 127.4, 128.4, 131.9, 142.9, 145.1 ppm. HRESI-MS calcd. For
[C17H15NO2 +H] (M++H) 266.118; found: 266.123.

Methyl 5,6,7a,8-tetrahydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]benzo[g]quinoline-7carboxylate, (±) romucosine (8), and methyl 5,6-dihydro-7H-[1,3]dioxolo[4',5':4,5] benzo[1,2,3de]benzo[g]quinoline-7-carboxylate, [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]methylcarbamate (9):
The salt mixture of 6 and 7 (89 mg) in dry CH2Cl2 (40 mL) was treated with triethylamine
(6.00 equiv.) in a round-bottom flask with a magnetic stir-bar at 0 °C for 10 min, then methyl
chlorocarbonate (8.08 mL) was slowly added. The reaction mixture was stirred for 1 hr, and H2O
was added to quench excess reagent. The mixture was partitioned with CHCl 3 and dried with
MgSO4, filtered, evaporated and then purified by chromatography on column using hexane/EtOAc
mixtures as the eluent to afford 64 mg of (±) romucosine 8 and 16 mg of [2-(3,4-methylenedioxy1-phenanthrenyl)ethyl]-methylcarbamate 9.
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1H

NMR of (±) romucosine 8 (500 MHz, CDCl3): δ = 2.64 (dt, J = 15.48, 2.37 Hz, 1 H),

2.77–3.13 (m, 4 H), , 3.79 (s, 3 H), 4.45 (brs, 1 H), 4.88 (d, J = 13.54 Hz, 1 H), 5.99 (d, J = 1.49
Hz, 1 H), 6.12 (d, J = 1.5 Hz, 1 H), 6.632 (s, 1 H), 7.27–7.31 (m, 2 H), 7.35 (td, J = 7.55, 2.04 Hz,
1 H), 8.13 (dd, J = 7.71, 1.16 Hz, 1 H) ppm.
NMR (125 MHz, CDCl3): δ = 29.7, 30.3, 39.1, 51.6, 52.6, 100.9, 107.6, 117.4, 125.5,

13C

127.0, 127.1, 127.8, 127.8, 128.6, 130.7, 135.7, 143.0, 146.8, 155.4 ppm. HRESI-MS calcd. For
[C19H17NO4 +H+] (M+H+) 324.124 found: 324.128.
1H

NMR of [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate 9

(500

MHz, CDCl3): δ = 3.26 (t, J = 7.28 Hz, 2 H), 3.52 (q, J = 6.95 Hz, 2 H), 3.71 (s, 3 H), 6.23 (s, 2
H), 7.11 (s, 1 H), 7.54–7.67 (m, 3 H), 7.77–7.96 (m, 2 H), 9.10 (dd, J = 7.41, 1.9 Hz, 1 H) ppm.
13C NMR (125 MHz, CDCl3): δ =

33.9, 42.2, 52.1, 101.1, 110.7, 117.1, 122.5, 125.3, 126.1,

126.3, 126.8, 127.3, 127.6, 128.6, 129.4, 131.9, 142.4, 144.9, 157.1 ppm. HRESI-MS calcd. For
[C19H17NO4 +H] (M++H) 324.123 found: 324.128.

4.2.

Enantiomers resolution
4.2.1.

The recycling process of resolution using dibenzoyl tartaric acid.

At 0 °C, 10 mg of (±) bromo-tetrahydrobenzylisoquinoline 3 was dissolved in 1 mL of
ethyl acetate in a two-necked flask. Then, 10.35 mg of dibenzoyl tartaric acid was dissolved with
1 ml of ethyl acetate and was added to the alkaloid mixture and stirred for 10 min at room temp.
After that isopropanol (1.4 mL) was added and the mixture was heated at reflux (85 °C) Refluxing
was continued for 5 hrs, and the mixture was allowed to cool to room temperature and then to 0
°C in an ice bath, no precipitate was notice, and a lot of TLC spots have shown. We were not able
to separate the enantiomers using this reaction.
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4.2.2.

The enantiomers resolution with (-)(1R)-menthyl chloroformate.

(5R)-2-isopropyl-5-methylcyclohexyl (5S)-5-(2-bromobenzyl)-7,8-dihydro-[1,3]dioxolo[4,5g]isoquinoline-6(5H)-carboxylate (10), and (5R)-2-isopropyl-5-methylcyclohexyl (5R)-5-(2bromobenzyl)-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline-6(5H)-carboxylate (11):
(±) Bromo-tetrahydrobenzylisoquinoline 3 was dissolved in acetonitrile (10 mL), and (1.2
mL) of triethylamine was added, followed by (0.76 mL) of (-)(1R)-menthyl chloroformate
dropwise. The mixture was reacted for 30 minutes at room temperature. Then, the mixture was
concentrated and then purified by chromatography on column using hexane/EtOAc mixtures as
the eluent to afford 94 mg of 10 and 40 mg of 11.
1H

NMR and

13C

NMR analysis of compound 10 revealed the presence of two amide

rotamers present in a 1:1 ratio. 1H NMR of compound 10 (500 MHz, CDCl3): δ = 0.5 (d, J = 6.8
Hz, 1 H), 0.71 (d, J = 6.9 Hz, 1 H), 0.79 (d, J = 7.02 Hz, 2 H), 0.82–1.93 (m, 14 H), 2.63–2.69 (m,
1H), 2.72–2.99 (m, 1 H), 3.06 (ddd, J = 13.22, 9.83, 2.88 Hz, 1 H), 3.29 (dd, J = 13.62, 4.71 Hz, 1
H), 3.35–3.51 (m, 1 H), 4.27 (ddd, J = 13.34, 6.07, 2.90 Hz, 1 H), 4.41 (qd, J = 11.03, 4.29 Hz, 1
H), 5.37 (dd, J = 10.0, 4.46 Hz, 1 H), 5.92 (s, 1H), 5.94 (s, 1H), 6.60 (d, J = 9.33 Hz, 1 H), 6.68
(d, J = 3.08 Hz, 1 H), 7.04–7.14 (m, 2 H), 7.20 (t, J = 7.3 Hz, 1 H), 7.55 (dd, J = 7.96, 1.17 Hz, 1
H) ppm.
13C

NMR (125 MHz, CDCl3): δ = 16.7, 20.6, 21.4, 22.6, 24.8, 26.5, 29.0, 31.3, 34.3, 38.2,

42.6, 47.0, 54.4, 75.2, 100.8, 107.0, 108.6, 125.4, 127.3, 127.5, 128.2, 130.0, 131.4, 132.6, 137.7,
146.0, 146.4, 155.4 ppm. . HRESI-MS calcd. For [C28H34BrNO4 +H+] (M+H+): 528.175 found:
528.181.
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1H

NMR and

13C

NMR analysis of compound 11 as well revealed the presence of two

amide rotamers present in a 2:1 ratio. 1H NMR of compound 11 (500 MHz, CDCl3): δ = 0.66 (d,
J = 6.9 Hz, 1 H), 0.79 (d, J = 6.4 Hz, 1 H), 0.84 (d, J = 7.52 Hz, 2 H), 0.84–1.45 (m, 14 H), 2.65–
2.71 (m, 1H), 2.87–2.97 (m, 1 H), 3.01 (dd, J = 13.8, 10.7 Hz, 1 H), 3.25 (dd, J = 13.8, 3.6 Hz, 1
H), 3.36 (ddd, J = 13.3, 10.3, 4.3 Hz, 1 H), 4.24 (td, J = 10.8, 4.3 Hz, 1 H), 4.31–4.34 (m, 1 H),
5.47 (dd, J = 10.7, 3.5 Hz, 1 H), 5.94 (d, J = 1.6 Hz, 1H), 5.95 (d, J = 1.4 Hz, 1H), 6.62 (s, 1 H),
6.68 (s, 1 H), 7.05–7.12 (m, 2 H), 7.21 (td, J = 7.4, 1.2 Hz, 1 H), 7.57 (dd, J = 7.56, 1.18 Hz, 1 H)
ppm.
13C

NMR (125 MHz, CDCl3): δ = 16.6, 20.7, 23.5, 26.5, 28.5, 29.7, 31.0, 34.2, 36.9, 40.0,

42.9, 46.9, 53.5, 74.9, 100.9, 106.9, 108.6 125.3, 127.08, 127.5, 128.4, 130.0, 131.3, 132.6, 137.8,
146.0, 146.4, 155.9 ppm. HRESI-MS calcd. For [C28H34BrNO4 +H] (M++H): 528.175 found:
528.181.

5.

Conclusion

This study described the total synthesis of (±) anonaine, 3, 4-methylenedioxy-1phenanthreneethylamine, (±) romucosine, and [2-(3,4-methylenedioxy-1-phenanthrenyl)ethyl]methylcarbamate by using of direct arylation reactions with 3,4-methylenedioxyphenethylamine 1
and 2-bromophenylacetic acid 2 in the preparation of aporphine analogs.
We also described the separation of the enantiomers using different resolution reactions.
The resolution with (_)-menthyl chloroformate succeeded in separating the enantiomers. However,
the cleavage of menthyl chloroformate moiety proves difficulties.
Anonaine, 3, 4-methylenedioxy-1-phenanthreneethylamine, romucosine, and [2-(3,4methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate have subjected to the biological
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evaluation to understand how they would induce or reduce the cytotoxicity as well as the
neurotoxicity. Several studies have indicated the anticancer activities of anonaine, and it showed
an interesting anticancer effective towards all cancer cell lines in our study. The anticancer
activities of 3, 4-methylenedioxy-1-phenanthreneethylamine, romucosine, and [2-(3,4methylenedioxy-1-phenanthrenyl)ethyl]-methylcarbamate were reported here for the first time.
Anonaine (compound 6) was significantly toxic to the neurons at 5 µg/mL. Also, the
alkaloidal extract significantly decreased the viability of the neurons with increasing
concentration. All other extracts and synthesized compounds did not have a significant decrease
in neuron cells viability according to statistical analysis. However, all extracts were extremely
toxic to all tested cancer and normal cell lines, so further studies are needed to understand these
conflicting results.
Lastly, the presence of the synthesized alkaloids in Rollinia mucosa was studied by using
a targeted analysis of Rollinia mucosa fruits and seeds extracts using UHPLC-QToF-MS. Only
anonaine was detected from Rollinia mucosa fruits and seeds methanolic extracts and Rollinia
mucosa seeds alkaloidal extract.
We were not able to detect the presence of romucosine, which has been reported to be
isolated from Rollinia mucosa fruits. Our study suggested that romucosine and other Nmethoxycarbonyl alkaloids reported previously from Rollinia mucosa could be artifacts formed
during the acid-base extraction, or they might be found in different sub-species of Rollinia mucosa.
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1H

NMR (500 MHz, DMSO-d6) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)
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13C

NMR (125 MHz, DMSO-d6) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)
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DEPT 135 (DMSO-d6) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)
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HSQC (DMSO-d6) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)
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H-H COSY (DMSO-d6) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)
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HMBC (DMSO-d6) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)

121

IR (KBr) for (-)-Anolobine-9-O-β-D-glucopyranoside (1)

122

1H

NMR (500 MHz, CD3OD) for (-)-Anolobine (2)

123

13C

NMR (125 MHz, CD3OD) for (-)-Anolobine (2)

124

HSQC (CD3OD) for (-)-Anolobine (2)

125

COSY (CD3OD) for (-)-Anolobine (2)

126

HMBC (CD3OD) for (-)-Anolobine (2)

127

1H

NMR (400 MHz, CDCl3) for (-)-Norushinsunine (4)

128

13C

NMR (100 MHz, CDCl3) for (-)-Norushinsunine (4)

129

1H

NMR (400 MHz, CD3OD) for (+)-Coclaurine (8)

130

13C

NMR (100 MHz, CD3OD) for (+)-Coclaurine (8)

131

HSQC (CD3OD) for (+)-Coclaurine (8)

132

COSY (CD3OD) for (+)-Coclaurine (8)

133

HMBC (CD3OD) for (+)-Coclaurine (8)

134

NOESY (CD3OD) for (+)-Coclaurine (8)

135

APPENDIX 2. SUPPLEMENTARY DATA-CHAPTER V

136

Compound (3) (400 MHz, DMSO-d6) 1H NMR:

137

Compound (3) (DMSO-d6) DeptQ135 NMR:

138

Compound (3) HRESI-MS:

139

Compound (4) (400 MHz, CDCl3) 1H NMR:

140

Compound (4) (100 MHz, CDCl3) 13C NMR:

141

Compound (4) HRESI-MS:

142

Compound (5) (400 MHz, CDCl3) 1H NMR:

143

Compound (5) (100 MHz, CDCl3) 13C NMR:

144

Compound (5) HRESI-MS:

145

Compound (6) (400 MHz, CD3OD) 1H NMR:

146

Compound (6) (100 MHz, CD3OD) 13C NMR:

147

Compound (6) (CD3OD) COSY NMR:

148

Compound (6) (CD3OD) HSQC NMR:

149

Compound (6) (CD3OD) HMBC NMR:

150

Compound (6) HRESI-MS:

151

Compound (7) (500 MHz, CD3OD) 1H NMR:

Compound 7 CD3OD

152

Compound (7) (125 MHz, CD3OD) 13C NMR:

Compound 7 CD3OD

153

Compound (7) (CD3OD) HSQC NMR:

Compound 7 CD3OD

154

Compound (7) (CD3OD) COSY NMR:

Compound 7 CD3OD

155

Compound (7) (CD3OD) HMBC NMR:

Compound 7 CD3OD

156

Compound (7) HRESI-MS:

157

IR (KBr) for compound 7:

158

Compound (8) (400 MHz, CDCl3) 1H NMR:

159

Compound (8) (500 MHz, CDCl3) 13C NMR:

160

Compound (8) (CDCl3) COSY NMR:

161

Compound (8) (CDCl3) HSQC NMR:

162

Compound (8) (CDCl3) HMBC NMR:

163

Compound (8) HRESI-MS:

164

IR (KBr) for compound 8:

165

Compound (9) (500 MHz, CDCl3) 1H NMR:

Compound 9 CD3OD

166

Compound (9) (100 MHz, CDCl3) 13C NMR:

Compound 9 CD3OD

167

Compound (9) (CDCl3) COSY NMR:

Compound 9 CD3OD

168

Compound (9) (CDCl3) HSQC NMR:

Compound 9 CD3OD

169

Compound (9) (CDCl3) HMBC NMR:

Compound 9 CD3OD

170

Compound (9) HRESI-MS:

171

IR (KBr) for compound 9:

172

Compound (10) (500 MHz, CDCl3) 1H NMR:

173

Compound (10) (125 MHz, CDCl3)

13C

NMR:

174

Compound (10) (CDCl3) COSY NMR:

175

Compound (10) (CDCl3) HSQC NMR:

176

Compound (10) (CDCl3) HMBC NMR:

177

Compound (10) HRESI-MS:

178

Compound (11) (500 MHz, CDCl3) 1H NMR:

179

Compound (11) (125 MHz, CDCl3) 13C NMR:

180

Compound (11) (CDCl3) HSQC NMR:

181

Compound (11) (CDCl3) COSY NMR:

182

Compound (11) (CDCl3) HMBC NMR:

183

Compound (11) HRESI-MS:

184
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